losartan and exp3174

losartan has been researched along with exp3174 in 226 studies

Research

Studies (226)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's116 (51.33)18.2507
2000's62 (27.43)29.6817
2010's40 (17.70)24.3611
2020's8 (3.54)2.80

Authors

AuthorsStudies
Boyd, DB; Lin, HS; Rampersaud, AA; Steinberg, MI; Zimmerman, K1
Belvisi, L; Caliari, S; Canevotti, R; Cirillo, R; Fici, F; Paleari, F; Poma, D; Renzetti, AR; Salimbeni, A; Subissi, A1
Chakravarty, PK; Chang, RS; Chen, A; Chen, TB; Faust, KA; Gable, RA; Kivlighn, SD; Lotti, VJ; Naylor, EM; Zingaro, GJ1
Ashton, WT; Chakravarty, PK; Chang, LL; Chen, TB; Faust, KA; Flanagan, KL; Greenlee, WJ; Hutchins, SM; Naylor, EM; Patchett, AA1
Ashton, WT; Chang, RS; Chen, TB; Doss, GA; Faust, KA; Greenlee, WJ; Hutchins, SM; Kivlighn, SD; Lotti, VJ; Zingaro, GJ1
Ashton, WT; Chang, LL; Chang, RS; Chen, TB; Faust, KA; Flanagan, KL; Greenlee, WJ; Lotti, VJ; MacCoss, M; Strelitz, RA1
Bunker, AM; Connolly, C; Edmunds, JJ; Hamby, JM; Hodges, JC; Kesten, SJ; Kostlan, CR; Quin, J; Sircar, I; Winters, RT1
Benfield, P; Carini, DJ; Chiu, AT; Herblin, WF; Lee, RJ; Saye, JA; Smith, RD; Timmermans, PB; Wexler, RR; Wong, PC1
Altenbach, RJ; Basha, FZ; Boyd, SA; Brune, ME; Buckner, SA; Crowell, D; De, B; Drizin, I; Winn, M; Zydowsky, TM1
Ashton, WT; Cantone, CL; Chang, LL; Chang, RS; Chen, TB; Faust, KA; Hutchins, SM; Lotti, VJ; MacCoss, M; Strelitz, RA1
Amemiya, Y; Fujimoto, K; Furukawa, Y; Ikeda, M; Kanazaki, T; Kitahara, Y; Koike, H; Miyamoto, S; Mizuno, M; Sada, T; Shimoji, Y; Yanagisawa, H1
Goldberg, MR; Greenlee, WJ; Irvin, JD; Prendergast, K; Smith, RD; Timmermans, PB; Wexler, RR1
Almansa, C; Cavalcanti, FL; de Arriba, AF; Forn, J; García-Rafanell, J; Gómez, LA1
Krovat, EM; Langer, T1
Berellini, G; Cruciani, G; Mannhold, R1
Balsamo, A; Breschi, MC; Calderone, V; Digiacomo, M; Macchia, M; Martelli, A; Martinotti, E; Minutolo, F; Rapposelli, S; Rossello, A; Testai, L1
Giridhar, R; Murumkar, P; Naik, P; Yadav, MR1
Fukami, T; Hosomi, H; Iwamura, A; Nakajima, M; Yokoi, T1
Alajarín, R; Alvarez-Builla, J; Díez-Marqués, ML; García, G; Griera, M; Rodríguez-Puyol, D; Rodríguez-Puyol, M; Sánchez-Alonso, P; Serrano, I; Vaquero, JJ1
Abad-Santos, F; Cabaleiro, T; López-Rodríguez, R; Novalbos, J; Ochoa, D; Prieto-Pérez, R; Román, M; Talegón, M; Wojnicz, A1
Benachour, N; Vanderheyden, PML1
Cramer, J; Ernst, B; Sager, CP1
Brunner, HR; Christen, Y; Lee, RJ; Munafo, A; Nussberger, J; Waeber, B1
Brooks, DP; DePalma, PD; Ruffolo, RR1
Chen, SJ; Jin, H; Oparil, S; Wyss, JM; Yang, RH1
Bennett, T; Gardiner, SM; Kemp, PA; Widdop, RE4
Hood, JS; Kadowitz, PJ; Kaye, AD; McMahon, TJ; Minkes, RK; Nossaman, BD1
Clozel, JP; Fischli, W; Hess, P; Véniant, M1
Biollaz, J; Borland, RM; Brunner, HR; Christen, Y; Lee, RJ; Munafo, A; Nussberger, J; Shum, LY; Waeber, B1
Furtek, CI; Lo, MW1
Entzeroth, M; Mauz, AB; Van Meel, JC; Wienen, W1
Chakravarty, PK; Chang, RS; Clineschmidt, BV; Greenlee, WJ; Lotti, VJ; Mantlo, NB; Patchett, AA; Siegl, PK1
Chakravarty, PK; Chang, RS; Greenlee, WJ; Lotti, VJ; Mantlo, NB; Ondeyka, DL; Patchett, AA; Siegl, PK; Sweet, CS1
Brooks, DP; Edwards, RM; Fredrickson, TA; Gellai, M; Ruffolo, RR; Weinstock, J1
Duncia, JV; Hart, SD; Timmermans, PB; Wong, PC1
Carini, DJ; Chiu, AT; Duncia, JV; Johnson, AL; Price, WA; Timmermans, PB; Wells, GJ; Wexler, RR; Wong, PC1
Hart, SD; Timmermans, PB; Wong, PC1
Carini, DJ; Chiu, AT; Duncia, JV; Johnson, AL; Price, WA; Timmermans, PB; Wexler, RR; Wong, PC1
Baker, KM; Conrad, KM; Dostal, DE; Schorb, W; Singer, HA1
Ciccocioppo, R; Cirillo, R; Massi, M; Polidori, C; Pompei, P2
Baker, KM; Bhat, GJ; Conrad, KM; Thekkumkara, TJ; Thomas, WG1
Kunihara, M; Kushida, H; Morita, O1
Bartholomeusz, B; Widdop, RE1
Baker, KM; Dostal, DE; Du, J; Motel, TJ; Thekkumkara, TJ; Thomas, WG1
Christ, DD1
Berdeaux, A; Giudicelli, JF; Richard, V1
Berman, RS; Bradstreet, DC; Jallard, N; Saenz, A; Sweet, CS; Weidler, DJ1
Chakravarty, PK; Chen, R; Chiu, SH; Stearns, RA1
Guengerich, FP; Jeong, HG; Lee, H; Lee, HS; Rho, JK; Yun, CH1
Fink, GD; Gorbea-Oppliger, VJ1
Fujishima, K; Hachisu, M; Hui, C; Katano, K; Kawano, K; Konno, F; Nagura, J; Ogino, H; Yamamoto, M; Yasuda, S1
Bauer, JH; Reams, GP1
Cohen, RB; Delaney, CL; Dickinson, KE; Gu, Z; Moreland, S; Poss, MA; Powell, JR; Ryono, DE; Serafino, RP; Skwish, S1
Basso, N; Cannata, MA; Kurnjek, ML; Ruiz, P1
Hodgson, WC; Hopkins, BJ; Sutherland, SK1
Bennett, T; Gardiner, SM; Widdop, RE1
Chiu, AT; Keiser, J; Madison, AB; Nishimura, H; Patton, CM; Walker, OE1
Ishizaki, H; Ohtawa, M1
Ardaillou, R; Bizet, T; Chansel, D; Levy, B; Pham, P; Vandermeersch, S1
Bensoussan, M; Mitchell, T; Reilly, T; Ronco, PM; Timmermans, PB; Verroust, PJ1
Berdeaux, A; Ghaleh, B; Giudicelli, JF; Richard, V1
Aki, Y; Fukui, T; He, H; Iwao, H; Kimura, S; Miyatake, A; Nishiyama, A; Tamaki, T; Yamamoto, A; Yoshida, H1
Inada, Y; Kohara, Y; Kubo, K; Naka, T; Nishikawa, K; Noda, M; Ojima, M; Sanada, T; Shibouta, Y; Wada, T1
Christian, R; Düsing, R; Ko, Y; Meyer zu Brickwedde, MK; Sachinidis, A; Vetter, H; Weisser, P; Wieczorek, AJ1
Bellan, JA; Kadowitz, PJ; Minkes, RK; Osei, SY1
Nakashima, M; Ohtawa, M; Saitoh, K; Takayama, F; Yoshinaga, T1
Ardaillou, R; Badre, L; Cambar, J; Chansel, D; Czekalski, S; Vandermeersch, S1
Bjornsson, TD; Furtek, CI; Goldberg, MR; Lo, MW; Lu, H; McCrea, JB1
Edwards, RM; Stack, EJ; Trizna, W; Weinstock, J1
Deutsch, PJ; Goldberg, MR; Lo, MW; McCrea, JB; McWilliams, EJ; Wilson, SE1
Bradstreet, TE; Goldberg, MR; Höglund, P; Lo, MW; Ritter, MA1
Li, XC; Widdop, RE1
Dunham, EW; Zhang, X; Zimmerman, BG1
Bosch, SM; Diz, DI; Li, Z; Smith, TL1
Baan, J; Chang, PC; Pfaffendorf, M; van Zwieten, PA; Vermeij, P1
Christ, DD; Lam, GN; Wong, PC; Wong, YN1
Feng, YH; Husain, A; Karnik, SS; Liu, XP; Noda, K; Saad, Y1
Dunn, FW; Farhadian, F; Hamon, G; Ossart, C; Rappaport, L; Roux, MH; Sabri, K; Samuel, JL1
Caussade, F; Cazes, M; Cloarec, A; Desangle, V; Provost, D; Virone-Oddos, A1
Harada, Y; Hashimoto, Y; Murata, S; Naito, K; Narita, H1
Arendshorst, WJ; Chatziantoniou, C; Kurtz, A; Ruan, X; Wagner, C1
Armentano, RL; Barra, JG; Cabrera Fischer, EI; Levenson, J; Pichel, RH; Simon, A1
Goldsmith, DJ1
Furtek, CI; Lo, MW; Ritter, MA1
Baker, KM; Conrad, KM; Dostal, DE; Hunt, RA; McWhinney, CD1
Blum, RA; Boike, SC; Etheredge, R; Ilson, B; Jorkasky, DK; Kazierad, DJ; Martin, DE; Tenero, DM1
Fujimori, A; Inagaki, O; Kusayama, T; Okazaki, T; Satoh, Y; Shibasaki, M; Takanashi, M; Tokioka, T; Uchida, W; Yanagisawa, I1
Bai, SA; Christ, DD; Hellyer, P; Lankford, SM; Plummer, D1
Heller, J; Horácek, V1
Heller, J; Horácek, V; Kramer, HJ1
Fleischhauer, J; Hanrath, P; Klues, HG; Montino, H; Schwarz, ER; vom Dahl, J1
Fakhry, I; Farthing, D; Gehr, TW; Pedro, A; Sica, D1
Hong, KW; Kim, CD; Lee, SH; Yoo, SE1
Mangiapane, ML; Peters, BR1
Mutschler, E; Soldner, A; Spahn-Langguth, H1
Adams, KF; McQueen, RH; Patterson, JH; Pieper, JA; Williamson, KM1
Kaukonen, KM; Neuvonen, PJ; Olkkola, KT1
Mutschler, E; Palm, D; Soldner, A; Spahn-Langguth, H1
Kimura, R; Miyake, H; Nozawa, Y; Yamada, S1
Fujimori, A; Inagaki, O; Kikuchi, K; Okazaki, T; Shibasaki, M; Suga, A; Watanabe, T; Yanagisawa, I1
Busse, R; Fisslthaler, B; Fleming, I; Schini-Kerth, VB1
Brosnihan, KB; Ferrario, CM; Li, P1
Freel, RW; Hatch, M; Vaziri, ND1
Carini, DJ; Christ, DD; Duncia, JV; Pierce, ME1
Baik, EJ; Jung, YS; Lee, HJ; Lee, SH; Moon, CH1
Iouzalen, L; Marche, P; Stepien, O1
Bjornsson, T; Cribb, A; Gillen, L; Goldberg, MR; Lo, MW; McCrea, JB; Osborne, B; Rushmore, T; Spielberg, S; Waldman, S1
Harris, PJ; Hiranyachattada, S; Smart, ML1
Barbe, F; Crozatier, B; Guyene, TT; Hittinger, L; Houël, R; Su, J1
Abrahamsson, T; Adler, G; Brandt-Eliasson, U; Karp, L; Morsing, P; Ohlson, K; Renberg, L; Sjöquist, PO1
De Backer, JP; Fierens, FL; Vanderheyden, PM; Vauquelin, G1
Oberhauser, V; Rump, LC; Schwertfeger, E1
Garcha, RS; Hughes, AD; Sever, PS1
Gould, RJ; Grossman, W; Kusma, SE; Lynch, JJ; Painter, CA; Stump, GL; Thomas, JM; Wallace, AA1
Hashimoto, Y; Narita, H; Yabana, H1
Cheung, PK; Saward, L; Wilson, DP; Zahradka, P1
Hashimoto, Y; Minami, K; Narita, H; Ohashi, R1
Hara, K; Iwasa, T; Kamei, T; Takano, T1
Ardaillou, R; Chansel, D; Llorens-Cortes, C; Vandermeersch, S1
Coca, A; Giner, V1
Kato, H; Tajima, S; Takata, Y1
Caballero, R; Delpón, E; Longobardo, M; Tamargo, J; Valenzuela, C1
Benet, LZ; Christians, U; Mutschler, E; Soldner, A1
Casado, S; Castilla, C; Farré, J; Gómez, J; Guerra, JI; Jiménez, AM; López-Farré, A; Marcos, P; Montón, M; Núñez, A; Rico, L; Rodríguez-Feo, JA; Sánchez De Miguel, L1
Brophy, DF; Gehr, TW; Pedro, AA; Sica, DA1
Cervenka, L; Heller, J; Horácek, V; Kramer, HJ; Malý, J1
deBlois, D; Hou, Y; Lemay, J1
Casado, S; Farré, J; Gómez, J; Jiménez, A; López-Blaya, A; López-Farré, A; Montón, M; Núñez, A; Sánchez de Miguel, L; Zalba, LR1
Hatta, E; Levi, R; Maruyama, R; Smith, NC; Yasuda, K1
Casley, DJ; Dinh, DT; Fabiani, ME; Johnston, CI; Nassis, L1
Fice, D; Jamieson, A; Pollak, PT; Smith, GJ; Yeung, PK1
Alova, L; Georgiev, V; Stancheva, S1
Buczko, W; Chabielska, E; Chłopicki, S; Gryglewski, RJ; Koda, M1
Hanada, K; Ikeda, T; Ikemoto, F; Kawai, N; Nakao, M; Nishikibe, M; Ohta, H; Suzuki, J1
Jankowski, J; Schlüter, H; Schmid, A; Tepel, M; van der Giet, M; Zidek, W1
Avni, B; Dishi, V; Gips, M; Golik, A; Scapa, E; Soback, S; Weissgarten, Y; Zaidenstein, R1
Bassenge, E; Schwemmer, M; Sommer, O1
Dahl, ML; Dorado, P; Eliasson, E; Forslund-Bergengren, C; Llerena, A; Sjöqvist, F; Tybring, G; Yasar, U1
Böger, RH; Drexler, H; Forssmann, WG; Krämer, C; Luchtefeld, M; Schieffer, B; Schmidt, B; Sunkomat, J; Tsikas, D; Walden, M; Witte, J1
Rane, A; Sandberg, M; Xie, HJ; Yasar, U1
Koyama, M; Levi, R; Mackins, CJ; Seyedi, N1
Buczko, W; Chabielska, E; Kalinowski, L; Malinski, T; Matys, T1
Buczko, W; Kucharewicz, I; Matys, T; Pawlak, D; Pawlak, R1
Edvinsson, L; Malmsjö, M; Pantev, E; Stenman, E; Wackenfors, A1
Dobrucki, LW; Heitsch, H; Louka, FR; Malinski, T; Wiemer, G1
Chiba, S; Inada, Y; Nakane, T1
Boonstra, PW; Buikema, H; Lübeck, RH; van Buiten, A; van Gilst, WH; van Veldhuisen, DJ; Voors, AA; Wagenaar, LJ1
Hunyady, L; Kersemans, V; Le, MT; Szaszák, M; Vanderheyden, PM; Vauquelin, G1
De Backer, JP; Vanderheyden, P; Vauquelin, G; Verheijen, I1
Blaisdell, JA; Goldstein, JA; Hinderliter, AL; Lee, CR; Pieper, JA1
Bessard, G; Caron, F; Cracowski, JL; Hakim, A; Hoffmann, P; Sessa, C; Stanke-Labesque, F1
Lo, MW; Polinko, M; Riffel, K; Song, H1
Horiuchi, R; Iga, T; Kimura, K; Kubota, T; Okada, Y; Sekino, K; Yamada, Y; Yamamoto, K1
Alova, L; Georgiev, V; Stancheva, S; Velkova, M1
Bäcker, A; Heller, J; Horacek, V; Kramer, HJ; Vaneckova, I1
Dominiak, P; Häuser, W1
Buczko, W; Chabielska, E; Domaniewski, T; Kucharewicz, I; Matys, T; Pawlak, R1
Gogonea, C; Karnik, SS; Noda, K; Saad, Y; Takezako, T1
Daliani, I; Dimitriou, D; Kamoutsis, C; Kyrikou, I; Laggner, P; Mavromoustakos, T; Pitsas, A; Siapi, E; Zervou, M; Zoga, A; Zoumpoulakis, P1
Avery, MA; Benson, SC; Chittiboyina, A; Desai, P; Ho, CI; Kurtz, TW; Pershadsingh, HA; Pravenec, M; Qi, N; Wang, J1
Ivanova, NA; Preobrazhenskiĭ, DV; Sidorenko, BA; Soplevenko, AV; Stetsenko, TM1
Arguin, G; Auger-Messier, M; Chaloux, B; Escher, E; Guillemette, G; Leduc, R1
Oberhauser, V; Rump, LC; Sellin, L; Stegbauer, J; Vonend, O1
de Leeuw, PW; Fuss-Lejeune, MJ; Kroon, AA; Spiering, W1
Auger-Messier, M; Escher, E; Guillemette, G; Leduc, R; Turgeon, ES1
de Leeuw, PW; Kroon, AA; Spiering, W1
Frost, N; Kintscher, U; Lee, LD; Schmidt, B; Schupp, M; Umbreen, S; Unger, T1
Babaoglu, MO; Boruban, C; Bozkurt, A; Coskun, U; Gunel, N; Gunes, A; Hassan, M; Rane, A; Sencan, O; Yasar, U; Zengil, H1
Guilbaud, R; Kambhampati, SR; Lee, J; Marier, JF; Mathew, P; Moberly, J; Salazar, DE1
Calderone, V; Martinelli, A; Rapposelli, S; Tuccinardi, T1
Apostolou, C; Dotsikas, Y; Kolocouri, F; Kousoulos, C; Loukas, YL1
Koyabu, N; Kuwano, M; Murakami, H; Nakamura, T; Ohtani, H; Satoh, H; Sawada, Y; Tsujimoto, M; Uchiumi, T; Ushigome, F; Yamashita, F1
Danielyan, L; Gleiter, CH; Kabisch, D; Lourhmati, A; Proksch, B; Schmidt, B; Thiess, U; Umbreen, S; Verleysdonk, S1
Babaoglu, MO; Bilir, E; Bozkurt, A; Gunes, A; Yasar, U; Zengil, H1
Furtek, CI; Gehr, TW; Halstenson, CE; Keane, WF; Lipschutz, K; Lo, MW; Ritter, MA; Shahinfar, S; Shaw, WC; Sica, DA1
Chen, Y; Fan, L; Guo, D; Hu, DL; Li, Z; Peng, XJ; Qian, RH; Wang, G; Xiao, CQ; Zhou, HH1
Chen, BL; Fan, L; Hu, DL; Li, Q; Li, Z; Liu, J; Liu, ZQ; Tan, ZR; Tu, JH; Wang, G; Wang, LS; Zhang, W; Zhou, HH1
Bähr, IN; Fleck, E; Fritzsche, J; Goebel, M; Gust, R; Hässle, PL; Kappert, K; Kaufmann, J; Kintscher, U; Ott, I; Stawowy, P; Tsuprykov, O; Unger, T1
Beloqui, O; Bidegain, J; Díez, J; Fortuño, A; Hermida, J; López-Sagaseta, J; Robador, PA; Zalba, G1
Kundlik, ML; Patel, CN; Patel, DM; Patel, NK; Shah, HJ; Subbaiah, G; Suhagia, BN1
Iliodromitis, EK; Kokotos, G; Kremastinos, DT; Mavromoustakos, TM; Moutevelis-Minakakis, P; Politi, AP; Triantafyllidi, H; Zervou, MV; Zoga, AA; Zoumpoulakis, PG1
Arsenault, J; Cabana, J; Escher, E; Guillemette, G; Lanthier, L; Lavigne, P; Leduc, R; Lehoux, J1
Choi, DH; Choi, JS; Li, C1
Furukubo, T; Higuchi, K; Hirata, S; Izumi, S; Nishiguchi, K; Otagiri, M; Shima, D; Takara, K; Tsujimoto, M; Yamakawa, T; Yokota, H1
Choi, HG; Kim, HK; Lee, GS; Lee, WS; Seo, KH; Woo, JS; Yan, YD; Yong, CS1
Cho, YA; Choi, JS; Yang, SH1
Choi, DH; Choi, JS; Yang, SH1
Guo, T; Xia, DY; Yang, L; Zhao, LS1
Bae, JW; Bang, HK; Choi, CI; Chung, MW; Ha, JH; Jang, CG; Kang, BS; Keum, SK; Kim, BH; Kim, HD; Kim, MJ; Kim, YH; Lee, SY; Na, HS; Oh, DH; Oh, SG; Park, HJ; Park, JI; Shin, HJ1
Du, FY; Liu, AC; Liu, T; Lou, HX; Xing, J; Zhao, LX1
Kim, DH; Oh, KS; Park, SJ; Shin, JG; Shinde, DD1
Bae, JW; Choi, CI; Jang, CG; Lee, HI; Lee, SY; Lee, YJ1
de Andrés, F; Dorado, P; Llerena, A; Machín, E; Naranjo, ME; Peñas-Lledó, EM1
Batzias, G; Niopas, I; Spanakis, M; Vizirianakis, IS1
Chai, Y; Ma, W; Sun, S; Wang, B; Yuan, Y; Zhang, G; Zhang, H; Zhao, L1
Akamatsu, T; Chida, K; Inui, N; Karayama, M; Namiki, N; Tanaka, S; Uchida, S; Watanabe, H1
Guo, R; Li, R; Lv, C; Wang, B; Wang, X; Wei, C; Yao, H1
Choi, DH; Choi, JS1
Arslanbekova, SM; Golukhova, EZ; Kazakov, RE; Kuznetsova, EV; Smirnov, VV; Sychev, DA1
Breunig, M; Goepferich, A; Hennig, R; Pollinger, K; Veser, A1
Akdogan, A; Babaoglu, MO; Bertilsson, L; Bozkurt, A; Goktaş, MT; Hatta, F; Helldén, A; Kalkisim, S; Karaca, O; Kilic, L; Yasar, U1
Goepferich, A; Hennig, R; Kirchhof, S; Veser, A1
Antoun, R; Beanlands, RS; DaSilva, JN; deKemp, RA; Hadizad, T; Ismail, B; Lortie, M1
Srinivas, NR1
Breunig, M; Goepferich, A; Haunberger, A; Hennig, R; Ohlmann, A; Pollinger, K; Schweda, F; Staffel, J; Tamm, ER1
Jang, HJ; Kim, KB; Kim, YS; Ryu, SH1
Eliasson, E; Inotsume, N; Mukai, Y; Rane, A; Senda, A; Toda, T1
Wang, R; Wang, Y; Yu, X; Yuan, Y; Zhang, H1
Gribakina, OG; Kolyvanov, GB; Litvin, AA; Shevchenko, RV; Smirnov, VV; Zherdev, VP1
Clifford, PS; Davis, MJ; Hill, MA; Hong, K; Hong, Z; Meininger, GA; Sun, Z; Yang, Y; Zhao, G1
Beaumont, J; Díez, J; Fortuño, A; González, A; López, B; Miguel-Carrasco, JL; Moreno, MU; Ravassa, S; San José, G; Zalba, G1
Hu, Y; Shi, H; Shi, W; Ye, S; Zhang, H; Zhou, X1
Prusty, S; Sahu, PK; Singh, VK; Subudhi, BB1
Karalis, V; Karatza, E1
Chabielska, E; Gromotowicz-Poplawska, A; Nazarko-Sadowska, J1
Abadir, PM; Anders, NM; Bichara, MD; Buta, B; Carey, RM; de Cabo, R; Ferrucci, L; Gabrawy, MM; Khadeer, M; Kwak, MJ; Le, A; Lee, JL; Ma, L; Marx, R; Moaddel, R; Nidadavolu, L; Rudek, MA; Siragy, HM; Tian, J; Walston, JD; Westbrook, R; Wu, Y; Xue, QL; Yang, H; Yenokyan, G; Zhang, C1
Atmuri, NDP; Bernatchez, P; Cait, J; Ciufolini, MA; Donen, G; Dong, Y; Hughes, M; McNagny, KM; Pechkovsky, D; Sauge, E; Sin, DD; Tam, A; Tehrani, AY; Walker, MJA; White, Z; Yuen, C1
Bester, K; Kisielius, V; Li, R; Liang, C; Svendsen, SB1
Akmalova, KA; Asoskova, AV; Boyarko, AV; Fisenko, VP; Grishina, EA; Mirzaev, KB; Sinitsina, II; Sozaeva, ZA; Sychev, DA; Temirbulatov, II1
Alfarraj, S; Alharbi, SA; Almoallim, HS; Ansari, MJ; Dar, AA; Dar, SA; Hassan, GI; Jan, I; Khan, NA; Mir, KB; Raina, A; Sofi, JA; Tarique, M; Wani, TA; Wani, TU1
da Silva Sólon, LG; Martin-Pastor, M; Queiroz, KA; Santos, ISR; Sousa, FFO; Tavares Júnior, AG1
Bai, J; Cai, L; Miao, Z; Si, Y; Sun, J; Wei, Y; Xiao, Y; Xing, W; Ye, H1

Reviews

11 review(s) available for losartan and exp3174

ArticleYear
Angiotensin II receptors and angiotensin II receptor antagonists.
    Pharmacological reviews, 1993, Volume: 45, Issue:2

    Topics: Amino Acid Sequence; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Cloning, Molecular; Hemodynamics; Humans; Hypertension; Imidazoles; Kidney; Losartan; Molecular Sequence Data; Pyridines; Receptors, Angiotensin; Tetrazoles

1993
Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy.
    Journal of medicinal chemistry, 1996, Feb-02, Volume: 39, Issue:3

    Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Humans; Receptors, Angiotensin; Structure-Activity Relationship

1996
Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists--a perspective.
    Bioorganic & medicinal chemistry, 2010, Dec-15, Volume: 18, Issue:24

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Antihypertensive Agents; Humans; Losartan

2010
Influence of the cellular environment on ligand binding kinetics at membrane-bound targets.
    Bioorganic & medicinal chemistry letters, 2017, 08-15, Volume: 27, Issue:16

    Topics: Angiotensin II Type 1 Receptor Blockers; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Humans; Kinetics; Ligands; Protein Binding; Receptor, Angiotensin, Type 1; Receptors, Cell Surface; Signal Transduction

2017
Hydroxyl Groups in Synthetic and Natural-Product-Derived Therapeutics: A Perspective on a Common Functional Group.
    Journal of medicinal chemistry, 2019, 10-24, Volume: 62, Issue:20

    Topics: Biological Products; Hydrogen Bonding; Hydroxyl Radical; Ligands; Thermodynamics

2019
Angiotensin II receptor antagonists. From discovery to antihypertensive drugs.
    Hypertension (Dallas, Tex. : 1979), 1991, Volume: 18, Issue:5 Suppl

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Humans; Imidazoles; Losartan; Receptors, Angiotensin; Tetrazoles

1991
The angiotensin II type 1 receptor antagonists. A new class of antihypertensive drugs.
    Archives of internal medicine, 1995, Jul-10, Volume: 155, Issue:13

    Topics: Acrylates; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Humans; Imidazoles; Irbesartan; Losartan; Pyridines; Quinolines; Telmisartan; Tetrazoles; Thiophenes; Valine; Valsartan

1995
The discovery and development of angiotensin II antagonists.
    Pharmaceutical biotechnology, 1998, Volume: 11

    Topics: Angiotensin II; Animals; Humans; Imidazoles; Losartan; Structure-Activity Relationship; Tetrazoles

1998
[Antihypertensive advantages of angiotensin II AT1 receptor antagonism].
    Revista espanola de cardiologia, 1999, Volume: 52 Suppl 3

    Topics: Aged; Angiotensin II; Angiotensin Receptor Antagonists; Anti-Arrhythmia Agents; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Clinical Trials as Topic; Heart Diseases; Heart Failure; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan

1999
Efforts to understand the molecular basis of hypertension through drug:membrane interactions.
    Current topics in medicinal chemistry, 2004, Volume: 4, Issue:4

    Topics: Amino Acids; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Binding Sites; Biphenyl Compounds; Calorimetry, Differential Scanning; Cell Membrane; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Magnetic Resonance Spectroscopy; Models, Molecular; Receptor, Angiotensin, Type 1; Tetrazoles; X-Ray Diffraction

2004
[Candesartan - a novel AT(1)-angiotensin receptor blocker: peculiarities of pharmacology and experience of use in arterial hypertension].
    Kardiologiia, 2004, Volume: 44, Issue:1

    Topics: Acrylates; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetic Nephropathies; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Tetrazoles; Thiophenes; Valine; Valsartan

2004

Trials

29 trial(s) available for losartan and exp3174

ArticleYear
Clinical experience with angiotensin II receptor antagonists.
    American journal of hypertension, 1992, Volume: 5, Issue:12 Pt 2

    Topics: Administration, Oral; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Humans; Hypertension; Imidazoles; Injections, Intravenous; Losartan; Renin-Angiotensin System; Tetrazoles; Time Factors

1992
Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist.
    Clinical pharmacology and therapeutics, 1992, Volume: 51, Issue:5

    Topics: Administration, Oral; Adult; Aldosterone; Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biotransformation; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Humans; Imidazoles; Losartan; Male; Reference Values; Renin; Tetrazoles

1992
Pharmacodynamic activity of intravenous E-3174, an angiotensin II antagonist, in patients with essential hypertension.
    American journal of hypertension, 1994, Volume: 7, Issue:12

    Topics: Adult; Aged; Angiotensin II; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Imidazoles; Injections, Intravenous; Kidney Function Tests; Losartan; Male; Middle Aged; Renin; Tetrazoles; Uric Acid

1994
Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans.
    British journal of clinical pharmacology, 1993, Volume: 35, Issue:3

    Topics: Administration, Oral; Adult; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Biphenyl Compounds; Blood Pressure; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Heart Rate; Humans; Imidazoles; Losartan; Male; Middle Aged; Renin; Tetrazoles

1993
Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans.
    Clinical pharmacology and therapeutics, 1995, Volume: 58, Issue:6

    Topics: Administration, Oral; Adult; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Cross-Over Studies; Humans; Imidazoles; Infusions, Intravenous; Losartan; Male; Tetrazoles

1995
Phenobarbital minimally alters plasma concentrations of losartan and its active metabolite E-3174.
    Clinical pharmacology and therapeutics, 1996, Volume: 59, Issue:3

    Topics: Adult; Anticonvulsants; Antihypertensive Agents; Biphenyl Compounds; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Enzyme Induction; Humans; Hydrocortisone; Hypnotics and Sedatives; Imidazoles; Losartan; Male; Mixed Function Oxygenases; Phenobarbital; Reference Values; Single-Blind Method; Tetrazoles

1996
Effects of cimetidine on pharmacokinetics and pharmacodynamics of losartan, an AT1-selective non-peptide angiotensin II receptor antagonist.
    European journal of clinical pharmacology, 1995, Volume: 49, Issue:1-2

    Topics: Adult; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Cimetidine; Cross-Over Studies; Histamine H2 Antagonists; Humans; Hypertension; Imidazoles; Losartan; Male; Tetrazoles

1995
Effects of losartan on vasoconstrictor responses to angiotensin II in the forearm vascular bed of healthy volunteers.
    Cardiovascular research, 1996, Volume: 32, Issue:5

    Topics: Administration, Oral; Adult; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Depression, Chemical; Dose-Response Relationship, Drug; Forearm; Humans; Imidazoles; Infusions, Intra-Arterial; Losartan; Male; Plethysmography; Tetrazoles; Vascular Resistance; Vasoconstrictor Agents

1996
Effect of fluconazole on the pharmacokinetics of eprosartan and losartan in healthy male volunteers.
    Clinical pharmacology and therapeutics, 1997, Volume: 62, Issue:4

    Topics: Acrylates; Adult; Antifungal Agents; Antihypertensive Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 Enzyme System; Drug Administration Schedule; Fluconazole; Humans; Imidazoles; Losartan; Male; Middle Aged; Reference Values; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Tetrazoles; Thiophenes; Time Factors

1997
Fluconazole but not itraconazole decreases the metabolism of losartan to E-3174.
    European journal of clinical pharmacology, 1998, Volume: 53, Issue:6

    Topics: Adult; Antifungal Agents; Antihypertensive Agents; Aryl Hydrocarbon Hydroxylases; Cross-Over Studies; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Double-Blind Method; Drug Interactions; Female; Fluconazole; Humans; Imidazoles; Itraconazole; Losartan; Male; Mixed Function Oxygenases; Reference Values; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Tetrazoles

1998
A radioreceptor assay for the analysis of AT1-receptor antagonists. Correlation with complementary LC data reveals a potential contribution of active metabolites.
    Journal of pharmaceutical and biomedical analysis, 1998, Volume: 17, Issue:1

    Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Proteins; Chromatography, High Pressure Liquid; Double-Blind Method; Humans; Imidazoles; Losartan; Male; Placebos; Pyrimidines; Radioligand Assay; Rats; Rats, Wistar; Receptors, Angiotensin; Reference Values; Sensitivity and Specificity; Tetrazoles

1998
The pharmacokinetics and pharmacodynamics of losartan in continuous ambulatory peritoneal dialysis.
    Journal of clinical pharmacology, 2000, Volume: 40, Issue:4

    Topics: Adult; Antihypertensive Agents; Area Under Curve; Blood Pressure; Diastole; Female; Half-Life; Humans; Imidazoles; Kidney Failure, Chronic; Losartan; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Systole; Tetrazoles

2000
Effect of grapefruit juice on the pharmacokinetics of losartan and its active metabolite E3174 in healthy volunteers.
    Therapeutic drug monitoring, 2001, Volume: 23, Issue:4

    Topics: Adult; Anti-Arrhythmia Agents; Antihypertensive Agents; Area Under Curve; Beverages; Biological Availability; Chromatography, High Pressure Liquid; Citrus; Cross-Over Studies; Female; Half-Life; Humans; Imidazoles; Losartan; Male; Tetrazoles

2001
Pharmacokinetics of losartan and its metabolite E-3174 in relation to the CYP2C9 genotype.
    Clinical pharmacology and therapeutics, 2002, Volume: 71, Issue:1

    Topics: Administration, Oral; Adult; Alleles; Antihypertensive Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme System; Female; Genotype; Humans; Imidazoles; Losartan; Male; Middle Aged; Pharmacogenetics; Spain; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Sweden; Tetrazoles

2002
Angiotensin II receptor-independent antiinflammatory and antiaggregatory properties of losartan: role of the active metabolite EXP3179.
    Circulation research, 2002, Apr-19, Volume: 90, Issue:7

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Arachidonic Acid; Biotransformation; Cells, Cultured; Cyclooxygenase 2; Dinoprost; Drug Design; Endothelium, Vascular; Enzyme Activation; Female; Humans; Hypertension; Imidazoles; Inflammation; Intercellular Adhesion Molecule-1; Isoenzymes; Lipopolysaccharides; Losartan; Male; Membrane Proteins; Middle Aged; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; RNA, Messenger; Tetrazoles; Thromboxane A2; Up-Regulation; Vasoconstrictor Agents

2002
Simultaneous determination of losartan and EXP3174 in human plasma and urine utilizing liquid chromatography/tandem mass spectrometry.
    Journal of pharmaceutical and biomedical analysis, 2003, Sep-15, Volume: 33, Issue:1

    Topics: Antihypertensive Agents; Child, Preschool; Chromatography, High Pressure Liquid; Humans; Imidazoles; Indicators and Reagents; Losartan; Mass Spectrometry; Quality Control; Reference Standards; Reproducibility of Results; Tetrazoles

2003
Effect of the single CYP2C9*3 allele on pharmacokinetics and pharmacodynamics of losartan in healthy Japanese subjects.
    European journal of clinical pharmacology, 2003, Volume: 59, Issue:8-9

    Topics: Adult; Antihypertensive Agents; Aryl Hydrocarbon Hydroxylases; Blood Pressure; Cytochrome P-450 CYP2C9; Female; Genotype; Heart Rate; Humans; Imidazoles; Japan; Losartan; Male; Tetrazoles

2003
Genetic contribution to the acute effects of angiotensin II type 1 receptor blockade.
    Journal of hypertension, 2005, Volume: 23, Issue:4

    Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Diet, Sodium-Restricted; Drug Resistance; Female; Genotype; Humans; Hypertension; Imidazoles; Losartan; Male; Middle Aged; Polymorphism, Genetic; Receptor, Angiotensin, Type 1; Sodium Chloride, Dietary; Tetrazoles; Vascular Resistance

2005
Inhibitory effect of 5-fluorouracil on cytochrome P450 2C9 activity in cancer patients.
    Basic & clinical pharmacology & toxicology, 2006, Volume: 98, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Aryl Hydrocarbon Hydroxylases; Colorectal Neoplasms; Cytochrome P-450 CYP2C9; Female; Fluorouracil; Genotype; Humans; Imidazoles; Losartan; Male; Middle Aged; Oxidation-Reduction; Tetrazoles

2006
The effect of AST-120 on the single-dose pharmacokinetics of losartan and losartan acid (E-3174) in healthy subjects.
    Journal of clinical pharmacology, 2006, Volume: 46, Issue:3

    Topics: Adsorption; Adult; Angiotensin II Type 1 Receptor Blockers; Carbon; Cross-Over Studies; Dietary Fats; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Female; Food-Drug Interactions; Gastrointestinal Agents; Humans; Imidazoles; Losartan; Male; Oxides; Tetrazoles; Time Factors

2006
Inhibitory effect of valproic acid on cytochrome P450 2C9 activity in epilepsy patients.
    Basic & clinical pharmacology & toxicology, 2007, Volume: 100, Issue:6

    Topics: Adolescent; Adult; Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2C9; Drug Antagonism; Epilepsy; Female; Genotype; Humans; Imidazoles; Losartan; Male; Middle Aged; Polymerase Chain Reaction; Tetrazoles; Valproic Acid

2007
The pharmacokinetics of losartan in renal insufficiency.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1995, Volume: 13, Issue:1

    Topics: Adult; Antihypertensive Agents; Area Under Curve; Blood Pressure; Creatinine; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Imidazoles; Losartan; Male; Middle Aged; Renal Insufficiency; Tetrazoles

1995
Effect of soy extract administration on losartan pharmacokinetics in healthy female volunteers.
    The Annals of pharmacotherapy, 2009, Volume: 43, Issue:6

    Topics: Anti-Arrhythmia Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; China; Chromatography, Liquid; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Female; Glycine max; Humans; Imidazoles; Losartan; Plant Extracts; Tandem Mass Spectrometry; Tetrazoles; Time Factors; Young Adult

2009
Chronic treatment with losartan results in sufficient serum levels of the metabolite EXP3179 for PPARgamma activation.
    Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:4

    Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Biphenyl Compounds; Cell Movement; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Male; Middle Aged; Muscle Cells; PPAR gamma; Telmisartan; Tetrazoles

2009
Losartan metabolite EXP3179 blocks NADPH oxidase-mediated superoxide production by inhibiting protein kinase C: potential clinical implications in hypertension.
    Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:4

    Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Female; Humans; Hypertension; Imidazoles; Losartan; Male; Matrix Metalloproteinase 9; Middle Aged; NADPH Oxidases; Oxidative Stress; Oxygen; Phagocytes; Protein Kinase C; Signal Transduction; Superoxides; Tetrazoles

2009
Pharmacokinetics of losartan and its active carboxylic acid metabolite E-3174 in five ethnic populations of China.
    Journal of clinical pharmacy and therapeutics, 2012, Volume: 37, Issue:2

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Area Under Curve; Asian People; China; Chromatography, High Pressure Liquid; Female; Half-Life; Humans; Imidazoles; Losartan; Male; Tetrazoles; Tissue Distribution; Young Adult

2012
Effects of CYP2C9*1/*3 and *1/*13 on the pharmacokinetics of losartan and its active metabolite E-3174.
    International journal of clinical pharmacology and therapeutics, 2012, Volume: 50, Issue:9

    Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Asian People; Biotransformation; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2C9; Genotype; Half-Life; Humans; Imidazoles; Losartan; Metabolic Clearance Rate; Pharmacogenetics; Phenotype; Polymorphism, Genetic; Republic of Korea; Tetrazoles; Young Adult

2012
Prediction of area under the curve for a p-glycoprotein, a CYP3A4 and a CYP2C9 substrate using a single time point strategy: assessment using fexofenadine, itraconazole and losartan and metabolites.
    Drug development and industrial pharmacy, 2016, Volume: 42, Issue:6

    Topics: Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cross-Over Studies; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Drug Interactions; Humans; Itraconazole; Losartan; Polypharmacy; Terfenadine

2016
Serum Concentrations of Losartan Metabolites Correlate With Improved Physical Function in a Pilot Study of Prefrail Older Adults.
    The journals of gerontology. Series A, Biological sciences and medical sciences, 2022, 12-29, Volume: 77, Issue:12

    Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Frailty; Imidazoles; Losartan; Pilot Projects; Tetrazoles

2022

Other Studies

186 other study(ies) available for losartan and exp3174

ArticleYear
Nonpeptide angiotensin II receptor antagonists: synthetic and computational chemistry of N-[[4-[2-(2H-tetrazol-5-yl)-1-cycloalken-1- yl]phenyl]methyl]imidazole derivatives and their in vitro activity.
    Journal of medicinal chemistry, 1992, Jul-10, Volume: 35, Issue:14

    Topics: Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Computer Simulation; Imidazoles; In Vitro Techniques; Losartan; Male; Models, Molecular; Rabbits; Rats; Rats, Inbred Strains; Tetrazoles

1992
N-3-substituted pyrimidinones as potent, orally active, AT1 selective angiotensin II receptor antagonists.
    Journal of medicinal chemistry, 1995, Nov-24, Volume: 38, Issue:24

    Topics: Administration, Oral; Angiotensin Receptor Antagonists; Animals; Humans; Hypertension; Male; Models, Molecular; Molecular Conformation; Molecular Structure; Pyrimidinones; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thiophenes

1995
A highly potent, orally active imidazo[4,5-b]pyridine biphenylacylsulfonamide (MK-996; L-159,282): a new AT1-selective angiotensin II receptor antagonist.
    Journal of medicinal chemistry, 1994, Nov-25, Volume: 37, Issue:24

    Topics: Administration, Oral; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Dogs; Imidazoles; Macaca mulatta; Pyridines; Rats

1994
Triazolinone biphenylsulfonamide derivatives as orally active angiotensin II antagonists with potent AT1 receptor affinity and enhanced AT2 affinity.
    Journal of medicinal chemistry, 1994, Aug-19, Volume: 37, Issue:17

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Indicators and Reagents; Kinetics; Magnetic Resonance Spectroscopy; Male; Mesencephalon; Molecular Structure; Muscle, Smooth, Vascular; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Structure-Activity Relationship; Sulfonamides; Triazoles

1994
Nonpeptide angiotensin II antagonists derived from 1H-pyrazole-5-carboxylates and 4-aryl-1H-imidazole-5-carboxylates.
    Journal of medicinal chemistry, 1993, Nov-12, Volume: 36, Issue:23

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Blood Pressure; Carboxylic Acids; Chemical Phenomena; Chemistry, Physical; Imidazoles; Male; Molecular Structure; Pyrazoles; Rabbits; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship

1993
Triazolinones as nonpeptide angiotensin II antagonists. 1. Synthesis and evaluation of potent 2,4,5-trisubstituted triazolinones.
    Journal of medicinal chemistry, 1993, Aug-20, Volume: 36, Issue:17

    Topics: Angiotensin II; Animals; Binding Sites; Male; Muscle, Smooth, Vascular; Rabbits; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Triazoles

1993
Nonpeptide angiotensin II receptor antagonists. 2. Design, synthesis, and structure-activity relationships of 2-alkyl-4-(1H-pyrrol-1-yl)-1H-imidazole derivatives: profile of 2-propyl-1-[[2'-(1H-tetrazol-5-yl)-[1,1' -biphenyl]-4-yl]-methyl]-4-[2-(trifluoro
    Journal of medicinal chemistry, 1993, Aug-06, Volume: 36, Issue:16

    Topics: Angiotensin Receptor Antagonists; Animals; Aorta; Disease Models, Animal; GABA Antagonists; gamma-Aminobutyric Acid; Hypertension, Renal; Liver; Male; Muscle Contraction; Pyridines; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Structure-Activity Relationship

1993
2-(Alkylamino)nicotinic acid and analogs. Potent angiotensin II antagonists.
    Journal of medicinal chemistry, 1993, Sep-03, Volume: 36, Issue:18

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Biological Availability; Iodine Radioisotopes; Liver; Male; Muscle Contraction; Niacin; Nicotinic Acids; Rabbits; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Receptors, Angiotensin; Tetrazoles

1993
Nonpeptide angiotensin II antagonists derived from 4H-1,2,4-triazoles and 3H-imidazo[1,2-b][1,2,4]triazoles.
    Journal of medicinal chemistry, 1993, Mar-05, Volume: 36, Issue:5

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta; Binding, Competitive; Blood Pressure; Male; Molecular Structure; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Structure-Activity Relationship; Triazoles

1993
Nonpeptide angiotensin II receptor antagonists: synthesis, biological activities, and structure-activity relationships of imidazole-5-carboxylic acids bearing alkyl, alkenyl, and hydroxyalkyl substituents at the 4-position and their related compounds.
    Journal of medicinal chemistry, 1996, Jan-05, Volume: 39, Issue:1

    Topics: Acetylation; Adrenal Cortex; Amino Acid Sequence; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biological Availability; Cattle; Imidazoles; In Vitro Techniques; Kinetics; Male; Models, Molecular; Molecular Conformation; Molecular Sequence Data; Molecular Structure; Rats; Rats, Wistar; Receptors, Angiotensin; Structure-Activity Relationship

1996
Synthesis and structure-activity relationship of a new series of potent AT1 selective angiotensin II receptor antagonists: 5-(biphenyl-4-ylmethyl)pyrazoles.
    Journal of medicinal chemistry, 1997, Feb-14, Volume: 40, Issue:4

    Topics: Angiotensin I; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Pyrazoles; Rats; Structure-Activity Relationship; Tetrazoles

1997
Non-peptide angiotensin II receptor antagonists: chemical feature based pharmacophore identification.
    Journal of medicinal chemistry, 2003, Feb-27, Volume: 46, Issue:5

    Topics: Acrylates; Algorithms; Angiotensin II; Biphenyl Compounds; Databases, Factual; Imidazoles; Lactones; Losartan; Models, Molecular; Molecular Conformation; Pyridines; Quantitative Structure-Activity Relationship; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Sulfones; Tetrazoles; Thiophenes

2003
Pharmacophore, drug metabolism, and pharmacokinetics models on non-peptide AT1, AT2, and AT1/AT2 angiotensin II receptor antagonists.
    Journal of medicinal chemistry, 2005, Jun-30, Volume: 48, Issue:13

    Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Binding Sites; Biphenyl Compounds; Kinetics; Losartan; Models, Molecular; Molecular Conformation; Oxidation-Reduction; Pharmaceutical Preparations; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Structure-Activity Relationship; Tetrazoles

2005
New NO-releasing pharmacodynamic hybrids of losartan and its active metabolite: design, synthesis, and biopharmacological properties.
    Journal of medicinal chemistry, 2006, Apr-20, Volume: 49, Issue:8

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Drug Design; Drug Evaluation, Preclinical; Hypertension; In Vitro Techniques; Losartan; Male; Molecular Structure; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Structure-Activity Relationship; Time Factors

2006
CYP2C9-mediated metabolic activation of losartan detected by a highly sensitive cell-based screening assay.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:5

    Topics: Antihypertensive Agents; Aryl Hydrocarbon Hydroxylases; Benzbromarone; Biotransformation; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP2C9; Diclofenac; HEK293 Cells; Hep G2 Cells; Hepatocytes; Humans; Losartan; NF-E2-Related Factor 2; Semicarbazides; Sensitivity and Specificity; Time Factors; Uricosuric Agents

2011
New losartan-hydrocaffeic acid hybrids as antihypertensive-antioxidant dual drugs: Ester, amide and amine linkers.
    European journal of medicinal chemistry, 2012, Volume: 50

    Topics: Amides; Amines; Angiotensin II; Animals; Antihypertensive Agents; Antioxidants; Aorta, Thoracic; Caffeic Acids; Cells, Cultured; Esters; Hypertension; Losartan; Male; Molecular Structure; Muscle, Smooth, Vascular; Rats; Rats, Wistar; Structure-Activity Relationship; Vasoconstrictor Agents

2012
Evaluation of the relationship between sex, polymorphisms in CYP2C8 and CYP2C9, and pharmacokinetics of angiotensin receptor blockers.
    Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:1

    Topics: Alleles; Angiotensin Receptor Antagonists; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP2C9; Female; Half-Life; Humans; Male; Polymorphism, Genetic; Reference Values; Sex Factors

2013
Effect of captopril and the nonpeptide angiotensin II antagonists, SK&F 108566 and EXP3174, on renal function in dogs with a renal artery stenosis.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 263, Issue:2

    Topics: Acrylates; Angiotensin II; Animals; Blood Pressure; Captopril; Dogs; Dose-Response Relationship, Drug; Female; Glomerular Filtration Rate; Imidazoles; Inulin; Kidney; Losartan; Regional Blood Flow; Renal Artery Obstruction; Tetrazoles; Thiophenes

1992
Blocking hypothalamic AT1 receptors lowers blood pressure in salt-sensitive rats.
    Hypertension (Dallas, Tex. : 1979), 1992, Volume: 20, Issue:6

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anterior Hypothalamic Nucleus; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Diet; Heart Rate; Imidazoles; Losartan; Microinjections; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sodium Chloride; Tetrazoles

1992
Inhibition of the haemodynamic effects of angiotensin II in conscious rats by AT2-receptor antagonists given after the AT1-receptor antagonist, EXP 3174.
    British journal of pharmacology, 1992, Volume: 107, Issue:3

    Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Heart Rate; Hemodynamics; Imidazoles; Losartan; Male; Pyridines; Rats; Regional Blood Flow; Tetrazoles

1992
Inhibitory effects of DuP 753 and EXP3174 on responses to angiotensin II in pulmonary vascular bed of the cat.
    Journal of applied physiology (Bethesda, Md. : 1985), 1992, Volume: 73, Issue:5

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Gas Analysis; Cats; Endothelins; Female; Hydrogen-Ion Concentration; Imidazoles; Losartan; Male; Norepinephrine; Pulmonary Circulation; Serotonin; Tetrazoles; Vasopressins

1992
Effects of renin-angiotensin system blockade in guinea pigs.
    Hypertension (Dallas, Tex. : 1979), 1992, Volume: 19, Issue:3

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Bradykinin; Cilazapril; Cyclooxygenase Inhibitors; Disease Models, Animal; Furosemide; Guinea Pigs; Hypertension; Imidazoles; Indomethacin; Losartan; Nephrectomy; Oligopeptides; Pyridazines; Renin; Renin-Angiotensin System; Tetrazoles

1992
Simultaneous determination of a novel angiotensin II receptor blocking agent, losartan, and its metabolite in human plasma and urine by high-performance liquid chromatography.
    Journal of chromatography, 1992, Jan-17, Volume: 573, Issue:2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Biphenyl Compounds; Chromatography, High Pressure Liquid; Humans; Imidazoles; Losartan; Reproducibility of Results; Spectrophotometry, Ultraviolet; Tetrazoles

1992
Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
    Molecular pharmacology, 1992, Volume: 41, Issue:6

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Binding Sites; Biphenyl Compounds; Female; Imidazoles; In Vitro Techniques; Iodine Radioisotopes; Kinetics; Losartan; Male; Muscle Contraction; Peptides; Rabbits; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Tetrazoles

1992
In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 262, Issue:1

    Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Binding, Competitive; Biphenyl Compounds; Brain; Cell Membrane; Culture Techniques; Humans; Imidazoles; Losartan; Macaca mulatta; Muscle, Smooth, Vascular; Rabbits; Rats; Species Specificity; Tetrazoles

1992
In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 262, Issue:1

    Topics: Administration, Oral; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Female; Imidazoles; Injections, Intravenous; Losartan; Macaca mulatta; Male; Pressoreceptors; Pyridines; Rats; Rats, Inbred Strains; Tetrazoles

1992
Antihypertensive activity of the non-peptide angiotensin II receptor antagonist, SK&F 108566, in rats and dogs.
    Naunyn-Schmiedeberg's archives of pharmacology, 1992, Volume: 345, Issue:6

    Topics: Acrylates; Angiotensin I; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Dogs; Hemodynamics; Hypertension; Imidazoles; Losartan; Male; Rats; Rats, Inbred Strains; Tetrazoles; Thiophenes

1992
Nonpeptide angiotensin II receptor antagonists. Studies with DuP 753 and EXP3174 in dogs.
    European journal of pharmacology, 1991, Sep-24, Volume: 202, Issue:3

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Captopril; Dogs; Female; Furosemide; Imidazoles; Kidney; Kidney Function Tests; Losartan; Male; Pyridines; Radioimmunoassay; Renin-Angiotensin System; Tetrazoles

1991
Effect of angiotensin II antagonism on canine renal sympathetic nerve function.
    Hypertension (Dallas, Tex. : 1979), 1991, Volume: 17, Issue:6 Pt 2

    Topics: Angiotensin II; Animals; Blood Pressure; Captopril; Dogs; Electric Stimulation; Female; Imidazoles; Kidney; Losartan; Male; Norepinephrine; Pyridines; Saralasin; Sympathetic Nervous System; Tetrazoles; Vascular Resistance; Vasoconstriction

1991
Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent.
    The Journal of pharmacology and experimental therapeutics, 1990, Volume: 255, Issue:1

    Topics: Administration, Oral; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Imidazoles; In Vitro Techniques; Losartan; Male; Rabbits; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Tetrazoles

1990
Angiotensin II is a potent stimulator of MAP-kinase activity in neonatal rat cardiac fibroblasts.
    Journal of molecular and cellular cardiology, 1995, Volume: 27, Issue:5

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Newborn; Becaplermin; Calcium-Calmodulin-Dependent Protein Kinases; Carbachol; Cell Division; Cells, Cultured; DNA; Enzyme Activation; Fibroblasts; Heart Ventricles; Imidazoles; Immunoblotting; Losartan; Myocardium; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Tetrazoles

1995
The selective angiotensin AT1 receptor antagonist LR-B/081 potently inhibits drinking induced by central injection of angiotensin II in rats.
    European journal of pharmacology, 1995, Apr-24, Volume: 277, Issue:2-3

    Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Carbachol; Dose-Response Relationship, Drug; Drinking; Eating; Imidazoles; Injections, Intraventricular; Lethal Dose 50; Losartan; Male; Milk; Pyrimidinones; Rats; Rats, Wistar; Renin-Angiotensin System; Tetrazoles; Thiophenes

1995
Angiotensin II stimulates sis-inducing factor-like DNA binding activity. Evidence that the AT1A receptor activates transcription factor-Stat91 and/or a related protein.
    The Journal of biological chemistry, 1994, Dec-16, Volume: 269, Issue:50

    Topics: Angiotensin II; Animals; Animals, Newborn; Base Sequence; Cells, Cultured; DNA-Binding Proteins; Gene Expression Regulation; Imidazoles; In Vitro Techniques; Losartan; Molecular Sequence Data; Myocardium; Nuclear Proteins; Phosphotyrosine; Promoter Regions, Genetic; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Signal Transduction; STAT1 Transcription Factor; Tetrazoles; Trans-Activators; Transcription Factors; Transcription, Genetic; Tyrosine

1994
Effects of U-97018 on pressor responses to intracerebroventricularly administered angiotensin II in conscious normotensive rats.
    Journal of cardiovascular pharmacology, 1995, Volume: 25, Issue:6

    Topics: Administration, Oral; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Imidazoles; Injections, Intravenous; Injections, Intraventricular; Losartan; Male; Pyridazines; Pyridines; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Saralasin; Tetrazoles

1995
Effect of acute and chronic treatment with the angiotensin II subtype 1 receptor antagonist EXP 3174 on baroreflex function in conscious spontaneously hypertensive rats.
    Journal of hypertension, 1995, Volume: 13, Issue:2

    Topics: Angiotensin Receptor Antagonists; Animals; Baroreflex; Blood Pressure; Heart Rate; Hypertension; Imidazoles; Losartan; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; Tetrazoles

1995
Stable expression of a functional rat angiotensin II (AT1A) receptor in CHO-K1 cells: rapid desensitization by angiotensin II.
    Molecular and cellular biochemistry, 1995, May-10, Volume: 146, Issue:1

    Topics: Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Base Sequence; Calcium; Cell Membrane; CHO Cells; Concanavalin A; Cricetinae; Gene Expression; Guanosine Triphosphate; Imidazoles; Losartan; Membrane Potentials; Molecular Sequence Data; Pyridines; Rats; Receptors, Angiotensin; Tetradecanoylphorbol Acetate; Tetrazoles; Transfection; Verapamil

1995
Human plasma protein binding of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) and its pharmacologically active metabolite EXP3174.
    Journal of clinical pharmacology, 1995, Volume: 35, Issue:5

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Blood Proteins; Humans; Imidazoles; Losartan; Protein Binding; Receptors, Angiotensin; Tetrazoles

1995
Central administration of PD 123319 or EXP-3174 inhibits effects of angiotensin II.
    The American journal of physiology, 1993, Volume: 264, Issue:1 Pt 2

    Topics: Angiotensin II; Animals; Brain; Hemodynamics; Imidazoles; Injections, Intraventricular; Losartan; Male; Pyridines; Rats; Rats, Inbred Strains; Substance P; Tetrazoles

1993
Systemic and coronary effects of the angiotensin II receptor antagonist EXP3174 in dogs.
    Journal of cardiovascular pharmacology, 1993, Volume: 22, Issue:1

    Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Coronary Circulation; Dogs; Enalaprilat; Female; Furosemide; Hemodynamics; Imidazoles; Losartan; Male; Renin-Angiotensin System; Tetrazoles

1993
Biotransformation of losartan to its active carboxylic acid metabolite in human liver microsomes. Role of cytochrome P4502C and 3A subfamily members.
    Drug metabolism and disposition: the biological fate of chemicals, 1995, Volume: 23, Issue:2

    Topics: Adult; Aged; Angiotensin Receptor Antagonists; Antibody Specificity; Antihypertensive Agents; Aryl Hydrocarbon Hydroxylases; B-Lymphocytes; Biotransformation; Biphenyl Compounds; Cell Line; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Imidazoles; Isoenzymes; Losartan; Male; Microsomes, Liver; NAD; NADP; Oxidation-Reduction; Oxidoreductases, N-Demethylating; Oxygen Isotopes; Recombinant Proteins; Spectrophotometry, Ultraviolet; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Subcellular Fractions; Tetrazoles

1995
Oxidation of the angiotensin II receptor antagonist losartan (DuP 753) in human liver microsomes. Role of cytochrome P4503A(4) in formation of the active metabolite EXP3174.
    Drug metabolism and disposition: the biological fate of chemicals, 1995, Volume: 23, Issue:2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzoflavones; Biotransformation; Biphenyl Compounds; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Humans; Imidazoles; Losartan; Microsomes, Liver; Mixed Function Oxygenases; Oxidation-Reduction; Receptors, Angiotensin; Tetrazoles

1995
Cerebroventricular injection of angiotensin II antagonist: effects on blood pressure responses to central and systemic angiotensin II.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 273, Issue:2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Imidazoles; Injections, Intraventricular; Losartan; Male; Microinjections; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Tetrazoles

1995
Pharmacological profile of ME3221, a novel angiotensin II receptor antagonist.
    European journal of pharmacology, 1995, Feb-14, Volume: 274, Issue:1-3

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta, Thoracic; Biphenyl Compounds; Blood Pressure; Bradykinin; Callithrix; Disease Models, Animal; Drug Evaluation; Female; Femoral Artery; Heart Rate; Hypertension, Renal; Imidazoles; Losartan; Male; Rabbits; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Species Specificity; Tetrazoles

1995
BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
    British journal of pharmacology, 1994, Volume: 113, Issue:1

    Topics: Adrenal Cortex; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Extracellular Space; Imidazoles; In Vitro Techniques; Losartan; Male; Membranes; Muscle Contraction; Muscle, Smooth, Vascular; Phosphatidylinositols; Rabbits; Rats; Tetrazoles

1994
Effect of EXP 3174 on blood pressure of normoreninemic renal hypertensive rats.
    Hypertension (Dallas, Tex. : 1979), 1995, Volume: 25, Issue:2

    Topics: Angiotensinogen; Animals; Antihypertensive Agents; Arteries; Blood Pressure; Hypertension, Renal; Imidazoles; Injections, Intravenous; Injections, Intraventricular; Losartan; Male; Rats; Rats, Wistar; Renin; Tetrazoles

1995
Pharmacological studies of stonefish (Synanceja trachynis) venom.
    Toxicon : official journal of the International Society on Toxinology, 1994, Volume: 32, Issue:10

    Topics: Animals; Biphenyl Compounds; Blood Pressure; Captopril; Chromones; Dose-Response Relationship, Drug; Fish Venoms; Fishes; Guinea Pigs; Heptanoic Acids; Histamine; Ileum; Imidazoles; In Vitro Techniques; Indomethacin; Losartan; Male; Mecamylamine; Muscle Contraction; Muscle, Smooth; Phospholipases A; Phospholipases A2; Quinacrine; Rats; Receptors, Thromboxane; Serotonin; SRS-A; Tetrazoles; Vas Deferens

1994
Effects of angiotensin II AT1- or AT2-receptor antagonists on drinking evoked by angiotensin II or water deprivation in rats.
    Brain research, 1994, Jun-13, Volume: 648, Issue:1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Drinking; Heart Rate; Imidazoles; Injections, Intraventricular; Losartan; Male; Pyridines; Rats; Rats, Brattleboro; Tetrazoles; Water Deprivation

1994
Novel angiotensin receptor subtypes in fowl.
    The American journal of physiology, 1994, Volume: 267, Issue:5 Pt 2

    Topics: Acetylcholine; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Abdominal; Biphenyl Compounds; Blood Pressure; Cell Membrane; Chickens; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Imidazoles; In Vitro Techniques; Kinetics; Losartan; Models, Cardiovascular; Muscle Contraction; Muscle, Smooth, Vascular; Pyridines; Receptors, Angiotensin; Reserpine; Tetrazoles

1994
Inhibitory effect of the nonpeptide angiotensin II receptor antagonist losartan and its active metabolite, E-3174, on cAMP phosphodiesterase: additional action of the antagonists.
    Biochemical pharmacology, 1994, Jul-05, Volume: 48, Issue:1

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Brain; Cattle; Imidazoles; Losartan; Tetrazoles

1994
Differential regulation of angiotensin II and losartan binding sites in glomeruli and mesangial cells.
    The American journal of physiology, 1994, Volume: 266, Issue:3 Pt 2

    Topics: Administration, Oral; Angiotensin II; Animals; Binding Sites; Biphenyl Compounds; Glomerular Mesangium; Imidazoles; In Vitro Techniques; Kidney Glomerulus; Losartan; Male; Rats; Rats, Wistar; Receptors, Angiotensin; RNA, Messenger; Saralasin; Tetrazoles

1994
Immunological reactivity of angiotensin II receptor antagonists: possible implications for receptor binding sites.
    European journal of pharmacology, 1993, Oct-15, Volume: 247, Issue:2

    Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antibodies, Monoclonal; Antihypertensive Agents; Biphenyl Compounds; Imidazoles; In Vitro Techniques; Indicators and Reagents; Iodine Radioisotopes; Losartan; Molecular Conformation; Oligopeptides; Pyridines; Rats; Receptors, Angiotensin; Saralasin; Tetrazoles

1993
Comparison of the effects of EXP3174, an angiotensin II antagonist and enalaprilat on myocardial infarct size in anaesthetized dogs.
    British journal of pharmacology, 1993, Volume: 110, Issue:3

    Topics: Anesthesia; Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Coronary Circulation; Disease Models, Animal; Dogs; Enalaprilat; Female; Furosemide; Heart Rate; Imidazoles; Injections, Intravenous; Losartan; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Renin-Angiotensin System; Tetrazoles

1993
Effects of EXP3174, a non-peptide angiotensin II receptor antagonist, on renal hemodynamics and renal function in dogs.
    European journal of pharmacology, 1993, May-12, Volume: 236, Issue:1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Body Water; Dogs; Glomerular Filtration Rate; Heart Rate; Imidazoles; Infusions, Intra-Arterial; Kidney; Kidney Function Tests; Losartan; Renal Circulation; Sodium; Tetrazoles

1993
Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethy
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 266, Issue:1

    Topics: Adrenal Cortex; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cattle; Imidazoles; In Vitro Techniques; Iodine Radioisotopes; Kinetics; Losartan; Male; Muscle Contraction; Muscle, Smooth, Vascular; Prodrugs; Protein Binding; Rabbits; Rats; Rats, Sprague-Dawley; Substrate Specificity; Tetrazoles

1993
Differential blockade of central effects of angiotensin II by AT2-receptor antagonists.
    The American journal of physiology, 1993, Volume: 265, Issue:1 Pt 2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Brain; Cardiovascular System; Imidazoles; Injections, Intraventricular; Losartan; Male; Pyridines; Rats; Tetrazoles

1993
EXP3174, a metabolite of losartan (MK 954, DuP 753) is more potent than losartan in blocking the angiotensin II-induced responses in vascular smooth muscle cells.
    Journal of hypertension, 1993, Volume: 11, Issue:2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Cells, Cultured; Female; Imidazoles; In Vitro Techniques; Losartan; Muscle, Smooth, Vascular; Rats; Rats, Inbred WKY; RNA, Messenger; Tetrazoles

1993
Analysis of the inhibitory effects of DuP 753 and EXP 3174 on responses to angiotensin II in the feline hindquarters vascular bed.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 264, Issue:3

    Topics: Angiotensin II; Angiotensin III; Animals; Biphenyl Compounds; Blood Pressure; Cats; Dose-Response Relationship, Drug; Female; Imidazoles; Losartan; Male; Perfusion; Tetrazoles

1993
Comparison of the regional haemodynamic effects of the AT1-receptor antagonists, losartan and EXP 3174, in water-deprived Brattleboro rats.
    British journal of pharmacology, 1993, Volume: 108, Issue:3

    Topics: Angiotensin I; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Hemodynamics; Imidazoles; Losartan; Male; Rats; Rats, Brattleboro; Regional Blood Flow; Tetrazoles; Time Factors; Water Deprivation

1993
Intrinsic properties of the nonpeptide angiotensin II antagonist losartan in glomeruli and mesangial cells at high concentrations.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 265, Issue:3

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Calcium; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Glomerular Mesangium; Humans; Imidazoles; Kidney Glomerulus; Losartan; Male; Rats; Rats, Sprague-Dawley; Tetrazoles; Vasoconstrictor Agents

1993
Interaction of nonpeptide angiotensin II receptor antagonists with the urate transporter in rat renal brush-border membranes.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 276, Issue:1

    Topics: Acrylates; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biological Transport; Biphenyl Compounds; Carbon Radioisotopes; Hydrogen-Ion Concentration; Imidazoles; Kidney; Kinetics; Losartan; Male; Microvilli; Naphthalenes; Rats; Rats, Sprague-Dawley; Tetrazoles; Thiophenes; Uric Acid

1996
Angiotensin type 1 receptor antagonists CV-11974 and EXP 3174 cause selective renal vasodilatation in conscious spontaneously hypertensive rats.
    Clinical science (London, England : 1979), 1996, Volume: 91, Issue:2

    Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Imidazoles; Losartan; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Circulation; Tetrazoles; Vasodilation

1996
Functional evidence for the ability of angiotensin AT1 receptor antagonists to cross the blood-brain barrier in rats.
    European journal of pharmacology, 1996, Jul-04, Volume: 307, Issue:3

    Topics: Administration, Oral; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Blood-Brain Barrier; Carbachol; Dose-Response Relationship, Drug; Drinking; Imidazoles; Injections, Intraperitoneal; Injections, Intraventricular; Losartan; Male; Nicotinic Acids; Pyrimidinones; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Tetrazoles; Thiophenes

1996
Threshold sodium excretory and renal blood flow effects of angiotensin converting enzyme inhibition.
    Journal of hypertension, 1995, Volume: 13, Issue:12 Pt 1

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Differential Threshold; Diuresis; Hemodynamics; Imidazoles; Losartan; Natriuresis; Nephrectomy; Potassium; Ramipril; Rats; Rats, Wistar; Renal Circulation; Tetrazoles; Vasodilation

1995
Interactions of nonpeptide angiotensin II receptor antagonists at imidazoline/guanidinium receptor sites in rat forebrain.
    Journal of cardiovascular pharmacology, 1996, Volume: 28, Issue:3

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Autoradiography; Biphenyl Compounds; Imidazoles; Losartan; Prosencephalon; Rats; Rats, Sprague-Dawley; Tetrazoles

1996
Nonpeptide angiotensin II receptor antagonist: pharmacokinetics and pharmacodynamics in rats of EXP3174, an active metabolite of losartan.
    Pharmacology, 1996, Volume: 52, Issue:1

    Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Half-Life; Imidazoles; Injections, Intravenous; Lethal Dose 50; Losartan; Male; Rats; Rats, Sprague-Dawley; Tetrazoles

1996
The active state of the AT1 angiotensin receptor is generated by angiotensin II induction.
    Biochemistry, 1996, Dec-24, Volume: 35, Issue:51

    Topics: Amino Acid Sequence; Angiotensin II; Animals; Binding Sites; COS Cells; Imidazoles; Kinetics; Losartan; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Protein Conformation; Protein Structure, Secondary; Rats; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Tetrazoles; Transfection

1996
HR 720, a novel angiotensin receptor antagonist inhibits the angiotensin II-induced trophic effects, fibronectin release and fibronectin-EIIIA+ expression in rat aortic vascular smooth muscle cells in vitro.
    The Journal of pharmacology and experimental therapeutics, 1997, Volume: 280, Issue:1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Biphenyl Compounds; Cells, Cultured; Fibronectins; Imidazoles; Leucine; Losartan; Male; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tetrazoles

1997
In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation.
    British journal of pharmacology, 1997, Volume: 120, Issue:3

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Carotid Arteries; Carotid Artery Injuries; Catheterization; Cell Division; Imidazoles; In Vitro Techniques; Losartan; Muscle Proteins; Muscle, Smooth, Vascular; Pyrimidines; Rats; Rats, Inbred SHR; Rats, Wistar; Stimulation, Chemical; Tetrazoles

1997
The pharmacologic profile of 606A, a novel angiotensin II receptor antagonist.
    Journal of cardiovascular pharmacology, 1997, Volume: 29, Issue:2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Cattle; Dogs; Female; Guinea Pigs; Imidazoles; Losartan; Male; Rabbits; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Tetrazoles; Vasoconstriction

1997
Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet.
    The Journal of clinical investigation, 1997, Mar-01, Volume: 99, Issue:5

    Topics: Actins; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Cloning, Molecular; Culture Techniques; DNA, Complementary; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Enalaprilat; Gene Expression Regulation; Imidazoles; Kidney; Losartan; Male; Oligopeptides; Polymerase Chain Reaction; Pyridines; Rats; Rats, Wistar; Receptors, Angiotensin; Renal Artery; Renal Circulation; Ribonucleases; RNA, Messenger; Sodium, Dietary; Tetrazoles; Vasoconstrictor Agents

1997
In vivo angiotensin II receptor blockade and converting enzyme inhibition on canine aortic viscoelasticity.
    The American journal of physiology, 1997, Volume: 272, Issue:2 Pt 2

    Topics: Angiotensin I; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Dogs; Elasticity; Enalaprilat; Hypertension, Renovascular; Imidazoles; Losartan; Male; Reference Values; Tetrazoles; Viscosity

1997
Angiotensin receptor antagonists.
    Lancet (London, England), 1997, Apr-26, Volume: 349, Issue:9060

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Humans; Hypertension; Imidazoles; Losartan; Scleroderma, Systemic; Tetrazoles

1997
An improved method for the simultaneous determination of losartan and its major metabolite, EXP3174, in human plasma and urine by high-performance liquid chromatography with fluorescence detection.
    Journal of pharmaceutical and biomedical analysis, 1997, Volume: 15, Issue:7

    Topics: Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Chromatography, High Pressure Liquid; Humans; Imidazoles; Losartan; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Tetrazoles

1997
The type I angiotensin II receptor couples to Stat1 and Stat3 activation through Jak2 kinase in neonatal rat cardiac myocytes.
    Journal of molecular and cellular cardiology, 1997, Volume: 29, Issue:9

    Topics: Angiotensin II; Animals; Animals, Newborn; Cells, Cultured; DNA-Binding Proteins; Heart; Imidazoles; Janus Kinase 2; Losartan; Myocardium; Nitriles; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; STAT1 Transcription Factor; STAT3 Transcription Factor; Tetrazoles; Trans-Activators; Transcription, Genetic; Tyrosine; Tyrphostins

1997
Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist.
    European journal of pharmacology, 1997, Sep-24, Volume: 335, Issue:2-3

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Azoles; Binding, Competitive; Biphenyl Compounds; Blood Pressure; Cattle; Decerebrate State; Imidazoles; In Vitro Techniques; Losartan; Male; Muscle, Smooth, Vascular; Pyridines; Rabbits; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles

1997
Pharmacokinetic-pharmacodynamic relations of losartan and EXP3174 in a porcine animal model.
    Journal of cardiovascular pharmacology, 1997, Volume: 30, Issue:5

    Topics: Angiotensin II; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Area Under Curve; Blood Pressure; Disease Models, Animal; Half-Life; Hypertension; Imidazoles; Infusions, Intravenous; Losartan; Receptors, Angiotensin; Swine; Tetrazoles

1997
Effect of PD 123319, an AT-2 antagonist, on renal function of the anesthetized dog: comparison with EXP 3174, an AT-1 blocker.
    Kidney & blood pressure research, 1997, Volume: 20, Issue:5

    Topics: Angiotensin Receptor Antagonists; Animals; Diuresis; Dogs; Drug Combinations; Glomerular Filtration Rate; Imidazoles; Injections, Intra-Arterial; Kidney; Losartan; Male; Natriuresis; Pyridines; Renal Circulation; Tetrazoles

1997
Comparative effects of the angiotensin II receptor blocker EXP 3174 and of the angiotensin-converting enzyme inhibitor captopril on renal glomerular hemodynamics in the dog.
    Kidney & blood pressure research, 1997, Volume: 20, Issue:6

    Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Flow Velocity; Blood Pressure; Bradykinin; Captopril; Dogs; Drug Combinations; Female; Glomerular Filtration Rate; Imidazoles; Kidney Glomerulus; Losartan; Male; Potassium; Sodium; Tetrazoles; Urea; Vascular Resistance; Vasodilation; Water

1997
Angiotensin II receptor antagonist EXP 3174 reduces infarct size comparable with enalaprilat and augments preconditioning in the pig heart.
    Cardiovascular drugs and therapy, 1997, Volume: 11, Issue:5

    Topics: Angiotensin Receptor Antagonists; Animals; Enalaprilat; Hemodynamics; Imidazoles; Losartan; Male; Myocardial Infarction; Myocardium; Swine; Tetrazoles

1997
Simple high-performance liquid chromatographic method for determination of losartan and E-3174 metabolite in human plasma, urine and dialysate.
    Journal of chromatography. B, Biomedical sciences and applications, 1997, Dec-19, Volume: 704, Issue:1-2

    Topics: Antihypertensive Agents; Chromatography, High Pressure Liquid; Dialysis Solutions; Humans; Imidazoles; Kidney Failure, Chronic; Losartan; Peritoneal Dialysis, Continuous Ambulatory; Sensitivity and Specificity; Tetrazoles

1997
The in vitro pharmacological profile of KR31080, a nonpeptide AT1 receptor antagonist.
    Fundamental & clinical pharmacology, 1998, Volume: 12, Issue:1

    Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Cattle; Cerebellum; Humans; Imidazoles; In Vitro Techniques; Iodine Radioisotopes; Losartan; Membranes; Muscle Contraction; Muscle, Smooth, Vascular; Pyridines; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Recombinant Proteins; Tetrazoles

1998
Role of nitric oxide in responses to renin-angiotensin system inhibition in sodium-depleted guinea pig and rat.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 1998, Volume: 20, Issue:2

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Dipeptides; Guinea Pigs; Imidazoles; Losartan; Male; Morpholines; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; Sodium; Tetrazoles

1998
HPLC assays to simultaneously determine the angiotensin-AT1 antagonist losartan as well as its main and active metabolite EXP 3174 in biological material of humans and rats.
    Journal of pharmaceutical and biomedical analysis, 1998, Volume: 16, Issue:5

    Topics: Angiotensin I; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Chromatography, High Pressure Liquid; Humans; Imidazoles; Losartan; Rats; Receptors, Angiotensin; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Tetrazoles; Tissue Distribution

1998
Effects of erythromycin or rifampin on losartan pharmacokinetics in healthy volunteers.
    Clinical pharmacology and therapeutics, 1998, Volume: 63, Issue:3

    Topics: Adult; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antihypertensive Agents; Drug Interactions; Erythromycin; Female; Humans; Imidazoles; Losartan; Male; Reference Values; Rifampin; Tetrazoles; Time Factors

1998
Receptor occupancy in myocardium, adrenal cortex, and brain by TH-142177, a novel AT1 receptor antagonist in rats, in relation to its plasma concentration and hypotensive effect.
    Pharmaceutical research, 1998, Volume: 15, Issue:6

    Topics: Adrenal Cortex; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Brain; Glycine; Imidazoles; Losartan; Male; Myocardium; Radioligand Assay; Rats; Rats, Wistar; Receptors, Angiotensin; Tetrazoles

1998
Studies on nonpeptide angiotensin II receptor antagonists. IV. Synthesis and biological evaluation of 4-acrylamide-1H-imidazole derivatives.
    Chemical & pharmaceutical bulletin, 1998, Volume: 46, Issue:6

    Topics: Acrylamides; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta, Thoracic; Blood Pressure; Diet, Sodium-Restricted; Disease Models, Animal; Diuretics; Dogs; Female; Furosemide; Hypertension; Imidazoles; Losartan; Male; Prodrugs; Rabbits; Rats; Rats, Wistar; Structure-Activity Relationship; Tetrazoles

1998
Thrombin receptor expression is increased by angiotensin II in cultured and native vascular smooth muscle cells.
    Cardiovascular research, 1998, Volume: 38, Issue:1

    Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Blotting, Northern; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Inhibitors; Imidazoles; In Vitro Techniques; Indoles; Losartan; Male; Muscle Contraction; Muscle, Smooth, Vascular; Polymerase Chain Reaction; Protein Kinase C; Rats; Rats, Wistar; Receptors, Thrombin; RNA, Messenger; Tetrazoles; Thrombin

1998
Losartan inhibits thromboxane A2-induced platelet aggregation and vascular constriction in spontaneously hypertensive rats.
    Journal of cardiovascular pharmacology, 1998, Volume: 32, Issue:2

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Angiotensin II; Animals; Antihypertensive Agents; Aorta; Endothelins; Endothelium, Vascular; Imidazoles; Losartan; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Inbred SHR; Receptors, Prostaglandin; Receptors, Thromboxane A2, Prostaglandin H2; Tetrazoles; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents

1998
Losartan antagonism of angiotensin-II-induced potassium secretion across rat colon.
    Pflugers Archiv : European journal of physiology, 1998, Volume: 436, Issue:5

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biological Transport; Colon; Dose-Response Relationship, Drug; Drug Antagonism; Extracellular Space; Hydrolysis; Imidazoles; In Vitro Techniques; Losartan; Male; Potassium; Pyridines; Rats; Rats, Sprague-Dawley; Rubidium Radioisotopes; Tetrazoles

1998
Pharmacokinetics of losartan and its metabolite, EXP3174, after intravenous and oral administration of losartan to rats with streptozotocin-induced diabetes mellitus.
    Research communications in molecular pathology and pharmacology, 1998, Volume: 101, Issue:2

    Topics: Administration, Oral; Animals; Antihypertensive Agents; Area Under Curve; Blood Glucose; Blood Proteins; Diabetes Mellitus, Experimental; Half-Life; Imidazoles; Injections, Intravenous; Losartan; Metabolic Clearance Rate; Rats; Rats, Sprague-Dawley; Tetrazoles

1998
Effects of BAY 10-6734 (Embusartan), a new angiotensin II type I receptor antagonist, on vascular smooth muscle cell growth.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 289, Issue:1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Calcium; Cell Division; Cells, Cultured; Cytosol; Dihydropyridines; DNA; Imidazoles; Losartan; Male; Muscle, Smooth, Vascular; Protein Biosynthesis; Radioligand Assay; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Species Specificity; Tetrazoles

1999
Phenotypic and genotypic investigations of a healthy volunteer deficient in the conversion of losartan to its active metabolite E-3174.
    Clinical pharmacology and therapeutics, 1999, Volume: 65, Issue:3

    Topics: Adult; Alleles; Anti-Arrhythmia Agents; Antihypertensive Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Genotype; Humans; Imidazoles; Losartan; Male; Mixed Function Oxygenases; Phenotype; Reference Values; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Tetrazoles; Volunteers

1999
Effects of angiotensin II receptor blockade on proximal fluid uptake in the rat kidney.
    British journal of pharmacology, 1999, Volume: 126, Issue:3

    Topics: Absorption; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Body Fluids; Dose-Response Relationship, Drug; Imidazoles; Kidney Tubules, Proximal; Losartan; Male; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles

1999
Comparison between angiotensin receptor antagonism and converting enzyme inhibition in heart failure. Differential acute effects according to the renin-angiotensin system activation.
    Basic research in cardiology, 1999, Volume: 94, Issue:2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Dogs; Enalaprilat; Female; Heart Failure; Hemodynamics; Imidazoles; Losartan; Male; Renin; Renin-Angiotensin System; Tetrazoles; Vasodilation

1999
Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin.
    Hypertension (Dallas, Tex. : 1979), 1999, Volume: 33, Issue:6

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blood Proteins; Female; Humans; Imidazoles; In Vitro Techniques; Irbesartan; Kinetics; Losartan; Male; Muscle Contraction; Muscle, Smooth, Vascular; Portal Vein; Rabbits; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles

1999
Insurmountable angiotensin AT1 receptor antagonists: the role of tight antagonist binding.
    European journal of pharmacology, 1999, May-14, Volume: 372, Issue:2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Binding, Competitive; Biphenyl Compounds; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Humans; Imidazoles; Irbesartan; Losartan; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Recombinant Proteins; Tetrazoles

1999
Interaction of the autonomic nervous and the renin-angiotensin system in heart and kidney.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1999, Volume: 14 Suppl 4

    Topics: Angiotensin II; Autonomic Nervous System; Heart; Humans; Imidazoles; Kidney; Losartan; Norepinephrine; Renin-Angiotensin System; Tetrazoles

1999
Action of AT1 receptor antagonists on angiotensin II-induced tone in human isolated subcutaneous resistance arteries.
    British journal of pharmacology, 1999, Volume: 127, Issue:8

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Arteries; Benzimidazoles; Biphenyl Compounds; Endothelium, Vascular; Humans; Imidazoles; Losartan; Muscle Tonus; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Vasoconstrictor Agents

1999
EXP3174, the AII antagonist human metabolite of losartan, but not losartan nor the angiotensin-converting enzyme inhibitor captopril, prevents the development of lethal ischemic ventricular arrhythmias in a canine model of recent myocardial infarction.
    Journal of the American College of Cardiology, 1999, Volume: 34, Issue:3

    Topics: Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Captopril; Disease Models, Animal; Dogs; Drug Evaluation, Preclinical; Female; Heart Ventricles; Humans; Imidazoles; Losartan; Male; Myocardial Infarction; Myocardial Ischemia; Tetrazoles; Time Factors

1999
Diverse effects of AT1 receptor antagonists on normal blood pressure and regulatory system.
    Hypertension research : official journal of the Japanese Society of Hypertension, 1999, Volume: 22, Issue:2

    Topics: Angiotensin Receptor Antagonists; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Blood Pressure; Heart Rate; Imidazoles; Losartan; Male; Pressoreceptors; Propranolol; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Glutamate; Reflex; Tetrazoles

1999
Angiotensin II receptor antagonists prevent neointimal proliferation in a porcine coronary artery organ culture model.
    Cardiovascular research, 1999, Volume: 42, Issue:3

    Topics: Analysis of Variance; Angioplasty, Balloon, Coronary; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Cell Division; Coronary Disease; Coronary Vessels; Culture Techniques; Imidazoles; Losartan; Muscle, Smooth, Vascular; Pyridines; Recurrence; Swine; Tetrazoles

1999
Comparative study of TA-606, a novel angiotensin II receptor antagonist, with losartan in terms of species difference and orthostatic hypotension.
    Japanese journal of pharmacology, 1999, Volume: 81, Issue:1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Dogs; Dose-Response Relationship, Drug; Hypertension, Renal; Hypotension, Orthostatic; Imidazoles; Losartan; Male; Prodrugs; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Species Specificity; Tetrazoles

1999
Method for the simultaneous determination of losartan and its major metabolite, EXP-3174, in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry.
    Journal of chromatography. B, Biomedical sciences and applications, 1999, Nov-12, Volume: 734, Issue:2

    Topics: Antihypertensive Agents; Chromatography, Liquid; Drug Stability; Humans; Imidazoles; Losartan; Mass Spectrometry; Quality Control; Sensitivity and Specificity; Tetrazoles

1999
Effects of angiotensin II and antagonists on AT(1) receptor expression in mesangial cells.
    European journal of pharmacology, 1999, Nov-19, Volume: 384, Issue:2-3

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Dexamethasone; Dose-Response Relationship, Drug; Gene Expression Regulation; Glomerular Mesangium; Imidazoles; Losartan; Male; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Tetrazoles

1999
Inhibitory effect of KT3-671, a non-peptide angiotensin subtype 1 receptor antagonist, on sympathetic neurotransmission in isolated rabbit aorta.
    Pharmacological research, 2000, Volume: 41, Issue:3

    Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Imidazoles; In Vitro Techniques; Losartan; Male; Norepinephrine; Rabbits; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Sympathetic Nervous System; Synaptic Transmission; Tetrazoles; Tritium

2000
Losartan and its metabolite E3174 modify cardiac delayed rectifier K(+) currents.
    Circulation, 2000, Mar-14, Volume: 101, Issue:10

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Cation Transport Proteins; DNA-Binding Proteins; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guinea Pigs; Heart; Heart Ventricles; Humans; Imidazoles; In Vitro Techniques; Kv1.5 Potassium Channel; Losartan; Potassium Channels; Potassium Channels, Voltage-Gated; Tetrazoles; Time Factors; Trans-Activators; Transcriptional Regulator ERG; Ventricular Function

2000
Active transport of the angiotensin-II antagonist losartan and its main metabolite EXP 3174 across MDCK-MDR1 and caco-2 cell monolayers.
    British journal of pharmacology, 2000, Volume: 129, Issue:6

    Topics: 2,4-Dinitrophenol; Angiotensin II; Animals; Anti-Arrhythmia Agents; Antimetabolites; Biological Transport, Active; Caco-2 Cells; Cell Line; Chromatography, Liquid; Dogs; Energy Metabolism; Epithelium; Humans; Imidazoles; Kidney; Kinetics; LLC-PK1 Cells; Losartan; Mass Spectrometry; Multidrug Resistance-Associated Protein 2; Swine; Temperature; Tetrazoles

2000
[Effect of losartan on human platelet activation by thromboxane A2].
    Revista espanola de cardiologia, 2000, Volume: 53, Issue:4

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Angiotensin II; Humans; Imidazoles; Losartan; Male; Platelet Activation; Receptors, Thromboxane; Tetrazoles; Thromboxane A2

2000
Effect of intrarenal infusion of angiotensin-(1-7) in the dog.
    Kidney & blood pressure research, 2000, Volume: 23, Issue:2

    Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Diuresis; Dogs; Female; Glomerular Filtration Rate; Imidazoles; Infusions, Intra-Arterial; Kidney; Losartan; Male; Peptide Fragments; Receptors, Angiotensin; Renal Artery; Renal Circulation; Tetrazoles; Urodynamics; Vasodilator Agents

2000
Evidence that nitric oxide regulates AT1-receptor agonist and antagonist efficacy in rat injured carotid artery.
    Journal of cardiovascular pharmacology, 2000, Volume: 35, Issue:5

    Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Carotid Arteries; Carotid Artery Injuries; Endothelium, Vascular; Enzyme Inhibitors; Imidazoles; Losartan; Male; Nitric Oxide; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Vasoconstriction

2000
Comparative effects of angiotensin II AT-1-type receptor antagonists in vitro on human platelet activation.
    Journal of cardiovascular pharmacology, 2000, Volume: 35, Issue:6

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Adult; Angiotensin II; Angiotensin Receptor Antagonists; Antibodies, Monoclonal; Benzimidazoles; Benzoates; Binding, Competitive; Biphenyl Compounds; Blood Platelets; Dose-Response Relationship, Drug; Humans; Imidazoles; Irbesartan; Losartan; Platelet Activation; Pyridines; Radioligand Assay; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Telmisartan; Tetrazoles; Thromboxane A2; Time Factors; Valine; Valsartan

2000
Angiotensin-converting enzyme-independent angiotensin formation in a human model of myocardial ischemia: modulation of norepinephrine release by angiotensin type 1 and angiotensin type 2 receptors.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 294, Issue:1

    Topics: Aged; Angiotensin II; Chymases; Female; Humans; Imidazoles; Losartan; Male; Middle Aged; Myocardial Ischemia; Norepinephrine; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Serine Endopeptidases; Tetrazoles

2000
In vivo inhibition of angiotensin receptors in the rat kidney by candesartan cilexetil: a comparison with losartan.
    American journal of hypertension, 2000, Volume: 13, Issue:9

    Topics: Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Imidazoles; Kidney; Losartan; Male; Membranes; Osmolar Concentration; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin; Tetrazoles

2000
Determination of plasma concentrations of losartan in patients by HPLC using solid phase extraction and UV detection.
    International journal of pharmaceutics, 2000, Aug-25, Volume: 204, Issue:1-2

    Topics: Antihypertensive Agents; Chromatography, High Pressure Liquid; Humans; Hypertension; Imidazoles; Losartan; Tetrazoles

2000
The effects of peptide and nonpeptide angiotensin II-receptor ligands on the activity of brain monoamine oxidase in water-repleted rats.
    Acta physiologica et pharmacologica Bulgarica, 2000, Volume: 25, Issue:2

    Topics: Angiotensin II; Animals; Body Water; Brain; Drinking; Imidazoles; Isoenzymes; Ligands; Losartan; Male; Monoamine Oxidase; Peptides; Rats; Rats, Wistar; Receptors, Angiotensin; Tetrazoles

2000
Antiplatelet action of losartan involves TXA2 receptor antagonism but not TXA2 synthase inhibition.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2000, Volume: 51, Issue:4 Pt 1

    Topics: Antihypertensive Agents; Blood Platelets; Collagen; Humans; Imidazoles; Losartan; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Thromboxane; Tetrazoles; Thromboxane-A Synthase; Valine; Valsartan

2000
Acute effects of E-3174, a human active metabolite of losartan, on the cardiovascular system in tachycardia-induced canine heart failure.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2001, Volume: 24, Issue:1

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiovascular System; Dogs; Echocardiography; Electric Stimulation; Enalapril; Heart Failure; Hemodynamics; Hormones; Imidazoles; Losartan; Male; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Renin-Angiotensin System; Tachycardia; Tetrazoles; Ventricular Function

2001
CoenzymeA glutathione disulfide is a potent modulator of angiotensin II-induced vasoconstriction.
    American journal of hypertension, 2001, Volume: 14, Issue:2

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Coenzyme A; Dose-Response Relationship, Drug; Imidazoles; In Vitro Techniques; Losartan; Male; Perfusion; Rats; Rats, Inbred WKY; Tetrazoles; Time Factors; Vasoconstriction; Vasomotor System

2001
Angiotensin receptor blocker losartan suppresses platelet activity by interfering with thromboxane signaling.
    Cardiovascular drugs and therapy, 2001, Volume: 15, Issue:4

    Topics: Angiotensin Receptor Antagonists; Animals; Arachidonic Acids; Benzimidazoles; Biphenyl Compounds; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Imidazoles; Losartan; Phospholipases A; Phospholipases A2; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Receptors, Thromboxane; Renin-Angiotensin System; Signal Transduction; Tetrazoles; Thromboxane A2

2001
Paeoniae Radix, a traditional Chinese medicine, and CYP2C9 activity.
    Journal of clinical pharmacy and therapeutics, 2002, Volume: 27, Issue:3

    Topics: Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Imidazoles; Losartan; Medicine, Chinese Traditional; Paeonia; Phytotherapy; Plant Preparations; Tetrazoles

2002
Ischemia promotes renin activation and angiotensin formation in sympathetic nerve terminals isolated from the human heart: contribution to carrier-mediated norepinephrine release.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 302, Issue:2

    Topics: Angiotensin II; Antihypertensive Agents; Female; Heart Atria; Heart Conduction System; Humans; Imidazoles; In Vitro Techniques; Losartan; Male; Middle Aged; Myocardial Ischemia; Norepinephrine; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin; Sympathetic Nervous System; Synaptosomes; Tetrazoles

2002
Angiotensin II AT1 receptor antagonists inhibit platelet adhesion and aggregation by nitric oxide release.
    Hypertension (Dallas, Tex. : 1979), 2002, Volume: 40, Issue:4

    Topics: Angiotensin Receptor Antagonists; Blood Platelets; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Imidazoles; Kinetics; Losartan; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptor, Angiotensin, Type 1; Tetrazoles; Valine; Valsartan

2002
Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7).
    Hypertension (Dallas, Tex. : 1979), 2002, Volume: 40, Issue:5

    Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Epoprostenol; Fibrinolytic Agents; Hypertension, Renal; Imidazoles; Infusions, Intravenous; Losartan; Male; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Venous Thrombosis

2002
Comparison of the antagonistic effects of different angiotensin II receptor blockers in human coronary arteries.
    European journal of heart failure, 2002, Volume: 4, Issue:6

    Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Base Sequence; Benzimidazoles; Biphenyl Compounds; Coronary Vessels; Culture Techniques; Dose-Response Relationship, Drug; Female; Humans; Imidazoles; Losartan; Male; Middle Aged; Molecular Sequence Data; Probability; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Valine; Valsartan; Vasoconstriction

2002
AVE 0991, a nonpeptide mimic of the effects of angiotensin-(1-7) on the endothelium.
    Hypertension (Dallas, Tex. : 1979), 2002, Volume: 40, Issue:6

    Topics: Angiotensin I; Animals; Binding, Competitive; Cattle; Cells, Cultured; Cricetinae; Electrochemistry; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; Humans; Imidazoles; Losartan; Molecular Mimicry; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Peptide Fragments; Pyridines; Radioligand Assay; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Substrate Specificity; Superoxides; Tetrazoles

2002
Binding of KRH-594, an antagonist of the angiotensin II type 1 receptor, to cloned human and rat angiotensin II receptors.
    Fundamental & clinical pharmacology, 2002, Volume: 16, Issue:4

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Chlorocebus aethiops; COS Cells; Dose-Response Relationship, Drug; Humans; Imidazoles; In Vitro Techniques; Liver; Losartan; Membranes; Oligopeptides; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Thiadiazoles; Time Factors; Transfection

2002
Functional antagonism of different angiotensin II type I receptor blockers in human arteries.
    Cardiovascular drugs and therapy, 2002, Volume: 16, Issue:4

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Benzimidazoles; Biphenyl Compounds; Dose-Response Relationship, Drug; Humans; Imidazoles; In Vitro Techniques; Losartan; Mammary Arteries; Muscle Contraction; Muscle, Smooth, Vascular; Receptor, Angiotensin, Type 1; Tetrazoles; Valine; Valsartan; Vasoconstrictor Agents

2002
Peptide and nonpeptide antagonist interaction with constitutively active human AT1 receptors.
    Biochemical pharmacology, 2003, Apr-15, Volume: 65, Issue:8

    Topics: Alanine; Amino Acid Substitution; Animals; Antihypertensive Agents; Aspartic Acid; Benzimidazoles; Biphenyl Compounds; CHO Cells; Cricetinae; Humans; Imidazoles; Kinetics; Losartan; Mutagenesis, Site-Directed; Radioligand Assay; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Tetrazoles; Transfection; Tritium

2003
A two-state model of antagonist-AT1 receptor interaction: further support by binding studies at low temperature.
    Biochemical pharmacology, 2003, Apr-15, Volume: 65, Issue:8

    Topics: Angiotensin Receptor Antagonists; Animals; Binding Sites; Biphenyl Compounds; CHO Cells; Cold Temperature; Computer Simulation; Cricetinae; Imidazoles; Irbesartan; Kinetics; Losartan; Models, Biological; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Recombinant Proteins; Tetrazoles; Thermodynamics; Transfection

2003
Losartan and E3174 pharmacokinetics in cytochrome P450 2C9*1/*1, *1/*2, and *1/*3 individuals.
    Pharmacotherapy, 2003, Volume: 23, Issue:6

    Topics: Adolescent; Adult; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C9; Female; Genotype; Half-Life; Humans; Imidazoles; Inactivation, Metabolic; Losartan; Male; Tetrazoles

2003
Functional comparison of the antagonistic properties of some Angiotensin II type 1 receptor blockers on the contraction elicited by Angiotensin II and thromboxane A2 on human saphenous veins.
    Journal of cardiovascular pharmacology, 2003, Volume: 42, Issue:1

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Drug Antagonism; Humans; Imidazoles; In Vitro Techniques; Irbesartan; Losartan; Muscle Contraction; Muscle, Smooth, Vascular; Receptors, Thromboxane A2, Prostaglandin H2; Saphenous Vein; Tetrazoles; Valine; Valsartan

2003
The effects of peptide and nonpeptide antagonists of angiotensin II receptors on the noradrenaline uptake of different brain structures in rats with angiotensin II-induced increase of water intake.
    Acta physiologica et pharmacologica Bulgarica, 2003, Volume: 27, Issue:2-3

    Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Brain; Drinking Behavior; Imidazoles; Losartan; Male; Norepinephrine; Rats; Rats, Wistar; Saralasin; Tetrazoles

2003
Relative roles of nitric oxide, prostanoids and angiotensin II in the regulation of canine glomerular hemodynamics. A micropuncture study.
    Kidney & blood pressure research, 2004, Volume: 27, Issue:1

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cyclooxygenase Inhibitors; Dogs; Enzyme Inhibitors; Female; Glomerular Filtration Rate; Hemodynamics; Imidazoles; Indomethacin; Kidney Glomerulus; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Prostaglandins; Renal Circulation; Tetrazoles; Time Factors

2004
[Dosage equivalents of AT1-receptor antagonists available in Germany].
    Deutsche medizinische Wochenschrift (1946), 2003, Oct-31, Volume: 128, Issue:44

    Topics: Acrylates; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Clinical Trials as Topic; Germany; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Olmesartan Medoxomil; Placebos; Telmisartan; Tetrazoles; Therapeutic Equivalency; Thiophenes; Time Factors; Valine; Valsartan

2003
Nitric oxide-dependent antiplatelet action of AT1-receptor antagonists in a pulmonary thromboembolism in mice.
    Journal of cardiovascular pharmacology, 2003, Volume: 42, Issue:6

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Imidazoles; Injections, Intraperitoneal; Losartan; Mice; Platelet Aggregation Inhibitors; Pulmonary Embolism; Rats; Tetrazoles; Valine; Valsartan

2003
"Network leaning" as a mechanism of insurmountable antagonism of the angiotensin II type 1 receptor by non-peptide antagonists.
    The Journal of biological chemistry, 2004, Apr-09, Volume: 279, Issue:15

    Topics: Amino Acid Sequence; Animals; Benzimidazoles; Binding, Competitive; Biphenyl Compounds; Cell Membrane; COS Cells; Dose-Response Relationship, Drug; Imidazoles; Kinetics; Ligands; Losartan; Models, Chemical; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Peptides; Protein Conformation; Rats; Receptor, Angiotensin, Type 1; Temperature; Tetrazoles; Time Factors

2004
Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity.
    Hypertension (Dallas, Tex. : 1979), 2004, Volume: 43, Issue:5

    Topics: Adipocytes; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Glucose; Cell Differentiation; Cells, Cultured; Chlorocebus aethiops; Drug Evaluation, Preclinical; Gene Expression Regulation; Imidazoles; Insulin; Irbesartan; Losartan; Male; Mice; Models, Molecular; Myoblasts; Protein Conformation; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Structure-Activity Relationship; Telmisartan; Tetrazoles; Thiazoles; Thiazolidinediones; Thiazolidines; Transcription Factors; Triglycerides; Valine; Valsartan; Weight Gain

2004
Down-regulation of inositol 1,4,5-trisphosphate receptor in cells stably expressing the constitutively active angiotensin II N111G-AT(1) receptor.
    Molecular endocrinology (Baltimore, Md.), 2004, Volume: 18, Issue:12

    Topics: Angiotensin II; Antihypertensive Agents; Calcium; Calcium Channels; Calcium Signaling; Cell Line; Down-Regulation; Embryo, Mammalian; Humans; Imidazoles; Inositol 1,4,5-Trisphosphate; Inositol 1,4,5-Trisphosphate Receptors; Kidney; Losartan; Receptor, Angiotensin, Type 1; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Tetrazoles; Thapsigargin

2004
Angiotensin II receptor modulation of renal vascular resistance and neurotransmission in young and adult spontaneously hypertensive rats.
    Kidney & blood pressure research, 2005, Volume: 28, Issue:1

    Topics: Aging; Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Imidazoles; Kidney; Losartan; Male; Norepinephrine; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WF; Receptor, Angiotensin, Type 1; Signal Transduction; Sympathetic Nervous System; Tetrazoles; Vascular Resistance; Vasoconstrictor Agents

2005
The constitutively active N111G-AT1 receptor for angiotensin II modifies the morphology and cytoskeletal organization of HEK-293 cells.
    Experimental cell research, 2005, Aug-01, Volume: 308, Issue:1

    Topics: Angiotensin II; Cell Line; Cell Shape; Cytoskeleton; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; Losartan; Mutation; Phenotype; Protein Serine-Threonine Kinases; Receptor, Angiotensin, Type 1; rho-Associated Kinases; Tetrazoles

2005
A116C angiotensin II type 1 receptor gene polymorphism may predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension.
    The American journal of gastroenterology, 2005, Volume: 100, Issue:11

    Topics: Adenine; Alleles; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Cytosine; Heart Rate; Humans; Hypertension, Portal; Imidazoles; Liver Cirrhosis; Losartan; Polymorphism, Genetic; Receptor, Angiotensin, Type 1; Tetrazoles

2005
Regulation of peroxisome proliferator-activated receptor gamma activity by losartan metabolites.
    Hypertension (Dallas, Tex. : 1979), 2006, Volume: 47, Issue:3

    Topics: 3T3-L1 Cells; Adipocytes; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Differentiation; Chlorocebus aethiops; COS Cells; Gene Expression; Imidazoles; Ligands; Losartan; Mice; PPAR gamma; Protein Structure, Tertiary; RNA, Messenger; Tetrazoles

2006
Proposal of a new binding orientation for non-peptide AT1 antagonists: homology modeling, docking and three-dimensional quantitative structure-activity relationship analysis.
    Journal of medicinal chemistry, 2006, Jul-13, Volume: 49, Issue:14

    Topics: Amino Acid Sequence; Angiotensin II Type 1 Receptor Blockers; Animals; Cattle; Crystallography, X-Ray; Imidazoles; Lipid Bilayers; Losartan; Models, Molecular; Molecular Sequence Data; Mutation; Phospholipids; Quantitative Structure-Activity Relationship; Receptor, Angiotensin, Type 1; Rhodopsin; Sequence Homology, Amino Acid; Tetrazoles

2006
Simultaneous determination of losartan, EXP-3174 and hydrochlorothiazide in plasma via fully automated 96-well-format-based solid-phase extraction and liquid chromatography-negative electrospray tandem mass spectrometry.
    Analytical and bioanalytical chemistry, 2007, Volume: 387, Issue:2

    Topics: Antihypertensive Agents; Chemical Fractionation; Drug Combinations; Drug Monitoring; Humans; Hydrochlorothiazide; Imidazoles; Losartan; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Tetrazoles

2007
Inhibitory effects of angiotensin II receptor antagonists and leukotriene receptor antagonists on the transport of human organic anion transporter 4.
    The Journal of pharmacy and pharmacology, 2006, Volume: 58, Issue:11

    Topics: Acetates; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biological Transport; Biphenyl Compounds; Blotting, Western; Cell Line; Chromones; Cyclopropanes; Dose-Response Relationship, Drug; Estrone; Humans; Imidazoles; Indoles; Leukotriene Antagonists; Losartan; Molecular Structure; Organic Anion Transporters, Sodium-Independent; Phenylcarbamates; Quinolines; Structure-Activity Relationship; Sulfides; Sulfonamides; Tetrazoles; Tosyl Compounds; Transfection; Tritium; Valine; Valsartan

2006
Angiotensin receptor type 1 blockade in astroglia decreases hypoxia-induced cell damage and TNF alpha release.
    Neurochemical research, 2007, Volume: 32, Issue:9

    Topics: Animals; Astrocytes; Cell Hypoxia; Cells, Cultured; Imidazoles; Losartan; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Tumor Necrosis Factor-alpha

2007
Effects of the CYP2C9*13 allele on the pharmacokinetics of losartan in healthy male subjects.
    Xenobiotica; the fate of foreign compounds in biological systems, 2009, Volume: 39, Issue:10

    Topics: Administration, Oral; Alleles; Antihypertensive Agents; Aryl Hydrocarbon Hydroxylases; Asian People; Cytochrome P-450 CYP2C9; Gene Frequency; Humans; Imidazoles; Losartan; Male; Tetrazoles; Young Adult

2009
Rapid determination of losartan and losartan acid in human plasma by multiplexed LC-MS/MS.
    Journal of separation science, 2009, Volume: 32, Issue:20

    Topics: Acids; Antihypertensive Agents; Chromatography, Liquid; Humans; Hydroflumethiazide; Imidazoles; Losartan; Molecular Structure; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Tetrazoles

2009
Hypertension study in anaesthetized rabbits: protocol proposal for AT1 antagonists screening.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2010, Volume: 11, Issue:2

    Topics: Anesthesia; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Hypertension; Imidazoles; Losartan; Rabbits; Receptor, Angiotensin, Type 1; Reproducibility of Results; Tetrazoles; Time Factors

2010
A single-nucleotide polymorphism of alanine to threonine at position 163 of the human angiotensin II type 1 receptor impairs Losartan affinity.
    Pharmacogenetics and genomics, 2010, Volume: 20, Issue:6

    Topics: Alanine; Angiotensin II; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Chlorocebus aethiops; COS Cells; Humans; Imidazoles; Inositol Phosphates; Irbesartan; Losartan; Polymorphism, Single Nucleotide; Receptor, Angiotensin, Type 1; Telmisartan; Tetrazoles; Threonine; Valine; Valsartan

2010
Effects of myricetin, an antioxidant, on the pharmacokinetics of losartan and its active metabolite, EXP-3174, in rats: possible role of cytochrome P450 3A4, cytochrome P450 2C9 and P-glycoprotein inhibition by myricetin.
    The Journal of pharmacy and pharmacology, 2010, Volume: 62, Issue:7

    Topics: Animals; Antioxidants; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Flavonoids; Herb-Drug Interactions; Imidazoles; Losartan; Male; Plant Extracts; Rats; Rats, Sprague-Dawley; Tetrazoles

2010
Inhibitory effects of uraemic toxins 3-indoxyl sulfate and p-cresol on losartan metabolism in vitro.
    The Journal of pharmacy and pharmacology, 2010, Volume: 62, Issue:1

    Topics: Angiotensin II Type 1 Receptor Blockers; Aryl Hydrocarbon Hydroxylases; Cresols; Cytochrome P-450 CYP2C9; Humans; Imidazoles; In Vitro Techniques; Indican; Kidney Failure, Chronic; Losartan; Microsomes, Liver; Renal Dialysis; Tetrazoles; Uremia

2010
The physicochemical properties, in vitro metabolism and pharmacokinetics of a novel ester prodrug of EXP3174.
    Molecular pharmaceutics, 2010, Dec-06, Volume: 7, Issue:6

    Topics: Animals; Chemistry, Physical; Dogs; Dose-Response Relationship, Drug; Esters; Humans; Hydrogen-Ion Concentration; Imidazoles; Intestinal Mucosa; Intestines; Liver; Losartan; Male; Molecular Structure; Prodrugs; Rats; Rats, Sprague-Dawley; Solubility; Stereoisomerism; Tetrazoles; Tissue Distribution

2010
Effects of ticlopidine on pharmacokinetics of losartan and its main metabolite EXP-3174 in rats.
    Acta pharmacologica Sinica, 2011, Volume: 32, Issue:7

    Topics: Animals; Antihypertensive Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Cell Line; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Humans; Imidazoles; Inhibitory Concentration 50; Losartan; Male; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Tetrazoles; Ticlopidine

2011
Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of losartan and its main metabolite EXP-3174 in rats: possible role of CYP3A4 and P-gp inhibition by HMG-CoA reductase inhibitors.
    Pharmacology, 2011, Volume: 88, Issue:1-2

    Topics: Acyl Coenzyme A; Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Anticholesteremic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Injections, Intravenous; Losartan; Lovastatin; Male; Rats; Rats, Sprague-Dawley; Rhodamine 123; Simvastatin; Tetrazoles; Time Factors

2011
Frequency of CYP2C9 alleles in Koreans and their effects on losartan pharmacokinetics.
    Acta pharmacologica Sinica, 2011, Volume: 32, Issue:10

    Topics: Adult; Alleles; Antihypertensive Agents; Aryl Hydrocarbon Hydroxylases; Asian People; Cytochrome P-450 CYP2C9; Gene Frequency; Genotype; Humans; Imidazoles; Losartan; Male; Tetrazoles; Young Adult

2011
Pre-treatment with curcumin enhances plasma concentrations of losartan and its metabolite EXP3174 in rats.
    Biological & pharmaceutical bulletin, 2012, Volume: 35, Issue:2

    Topics: Angiotensin Receptor Antagonists; Animals; Antioxidants; Area Under Curve; Chromatography, High Pressure Liquid; Curcumin; Female; Imidazoles; Losartan; Male; Rats; Rats, Wistar; Tandem Mass Spectrometry; Tetrazoles

2012
High-sensitivity liquid chromatography-tandem mass spectrometry for the simultaneous determination of five drugs and their cytochrome P450-specific probe metabolites in human plasma.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2012, May-01, Volume: 895-896

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Caffeine; Chromatography, Liquid; Cytochrome P-450 Enzyme System; Drug Stability; Humans; Imidazoles; Linear Models; Liquid-Liquid Extraction; Losartan; Omeprazole; Pharmaceutical Preparations; Reproducibility of Results; Tandem Mass Spectrometry; Tetrazoles; Theophylline

2012
Development of a HPLC method for the determination of losartan urinary metabolic ratio to be used for the determination of CYP2C9 hydroxylation phenotypes.
    Drug metabolism and drug interactions, 2012, Volume: 27, Issue:4

    Topics: Adult; Antihypertensive Agents; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2C9; Female; Genotype; Humans; Hydroxylation; Imidazoles; Losartan; Male; Middle Aged; Phenotype; Tetrazoles

2012
Pharmacokinetic interaction between losartan and Rhodiola rosea in rabbits.
    Pharmacology, 2013, Volume: 91, Issue:1-2

    Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Female; Herb-Drug Interactions; Imidazoles; Losartan; Plant Extracts; Rabbits; Rhodiola; Tetrazoles

2013
Influence of compound danshen tablet on the pharmacokinetics of losartan and its metabolite EXP3174 by liquid chromatography coupled with mass spectrometry.
    Biomedical chromatography : BMC, 2013, Volume: 27, Issue:9

    Topics: Animals; Chromatography, Liquid; Drug Stability; Drugs, Chinese Herbal; Herb-Drug Interactions; Imidazoles; Losartan; Male; Mass Spectrometry; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Salvia miltiorrhiza; Sensitivity and Specificity; Tetrazoles

2013
Chronological effects of rifampicin discontinuation on cytochrome P450 activity in healthy Japanese volunteers, using the cocktail method.
    Clinical pharmacology and therapeutics, 2013, Volume: 94, Issue:6

    Topics: Adult; Antibiotics, Antitubercular; Asian People; Caffeine; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Humans; Imidazoles; Losartan; Male; Midazolam; Omeprazole; Rifampin; Tetrazoles; Theophylline; Time Factors; Withholding Treatment

2013
The influence of food on the pharmacokinetics of amlodipine and losartan after single-dose of its compound tablets in healthy chinese subjects.
    Drug research, 2014, Volume: 64, Issue:5

    Topics: Administration, Oral; Adult; Amlodipine; Area Under Curve; Asian People; Female; Food; Food-Drug Interactions; Humans; Imidazoles; Losartan; Male; Tablets; Tetrazoles; Young Adult

2014
Effects of licochalcon A on the pharmacokinetics of losartan and its active metabolite, EXP-3174, in rats.
    Die Pharmazie, 2013, Volume: 68, Issue:11

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Area Under Curve; Chalcones; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dietary Supplements; Drug Interactions; Fluorescent Dyes; Half-Life; Imidazoles; Losartan; Male; Rats; Rats, Sprague-Dawley; Rhodamine 123; Tetrazoles

2013
[Relationship between warfarin dosing and activity of CYP2C9 assessed by the content of losartan and its metabolite E-3174 in the urine of patients with mechanical prosthetic heart valves].
    Kardiologiia, 2013, Volume: 53, Issue:12

    Topics: Adult; Anticoagulants; Aryl Hydrocarbon Hydroxylases; Biotransformation; Cardiovascular Agents; Cytochrome P-450 CYP2C9; Dose-Response Relationship, Drug; Drug Monitoring; Female; Genotype; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Imidazoles; Losartan; Male; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Postoperative Period; Tetrazoles; Warfarin

2013
Nanoparticle multivalency counterbalances the ligand affinity loss upon PEGylation.
    Journal of controlled release : official journal of the Controlled Release Society, 2014, Nov-28, Volume: 194

    Topics: Animals; Anti-Arrhythmia Agents; Cell Line, Tumor; Colloids; Drug Delivery Systems; Humans; Imidazoles; Ligands; Losartan; Nanoparticles; Polyethylene Glycols; Rats; Receptor, Angiotensin, Type 1; Tetrazoles

2014
Lower CYP2C9 activity in Turkish patients with Behçet's disease compared to healthy subjects: a down-regulation due to inflammation?
    European journal of clinical pharmacology, 2015, Volume: 71, Issue:10

    Topics: Adult; Aged; Alleles; Behcet Syndrome; Chromatography, High Pressure Liquid; Colchicine; Cytochrome P-450 CYP2C9; Cytokines; Down-Regulation; Female; Genotype; Humans; Imidazoles; Inflammation; Losartan; Male; Middle Aged; Phenotype; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Tetrazoles; Turkey

2015
Branched Polymer-Drug Conjugates for Multivalent Blockade of Angiotensin II Receptors.
    Molecular pharmaceutics, 2015, Sep-08, Volume: 12, Issue:9

    Topics: Animals; Antihypertensive Agents; Cells, Cultured; Dendrimers; Drug Carriers; Drug Delivery Systems; Half-Life; Imidazoles; Ligands; Losartan; Mesoderm; Polyamines; Polyethylene Glycols; Polymers; Rats; Receptors, Angiotensin; Tetrazoles

2015
Evaluation of [(11)C]methyl-losartan and [(11)C]methyl-EXP3174 for PET imaging of renal AT1receptor in rats.
    Nuclear medicine and biology, 2015, Volume: 42, Issue:11

    Topics: Animals; Carbon Radioisotopes; Imidazoles; Kidney; Losartan; Male; Positron-Emission Tomography; Radiochemistry; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Tetrazoles; Tissue Distribution

2015
Multivalent nanoparticles bind the retinal and choroidal vasculature.
    Journal of controlled release : official journal of the Controlled Release Society, 2015, Dec-28, Volume: 220, Issue:Pt A

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Binding, Competitive; Calcium Signaling; Capillaries; Choroid; Drug Carriers; HeLa Cells; Humans; Injections, Intravenous; Losartan; Mice; Protein Binding; Quantum Dots; Receptor, Angiotensin, Type 1; Retinal Vessels; Surface Properties; Tissue Distribution

2015
Negligible Pharmacokinetic Interaction of Red Ginseng and Losartan, an Antihypertensive Agent, in Sprague-Dawley Rats.
    Journal of toxicology and environmental health. Part A, 2015, Volume: 78, Issue:20

    Topics: Administration, Intravenous; Administration, Oral; Animals; Antihypertensive Agents; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Imidazoles; Losartan; Male; Panax; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry; Tetrazoles

2015
The Role of CYP2C8 and CYP2C9 Genotypes in Losartan-Dependent Inhibition of Paclitaxel Metabolism in Human Liver Microsomes.
    Basic & clinical pharmacology & toxicology, 2016, Volume: 118, Issue:6

    Topics: Antineoplastic Agents, Phytogenic; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP2C9; Genotype; Humans; Inhibitory Concentration 50; Losartan; Microsomes, Liver; Paclitaxel; Taxoids

2016
Effects of salvianolic acid B and tanshinone IIA on the pharmacokinetics of losartan in rats by regulating the activities and expression of CYP3A4 and CYP2C9.
    Journal of ethnopharmacology, 2016, Mar-02, Volume: 180

    Topics: Abietanes; Animals; Antihypertensive Agents; Benzofurans; Cell Line; Cell Survival; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Drug Interactions; Drugs, Chinese Herbal; Losartan; Male; Mass Spectrometry; Microsomes, Liver; Rats, Sprague-Dawley; RNA, Messenger

2016
[EVALUATION OF THE PHARMACOKINETIC INTERACTION OF AFOBAZOLE WITH CYP2C9 ENZYME DRUG SUBSTRATE OF CYTOCHROME P450].
    Eksperimental'naia i klinicheskaia farmakologiia, 2015, Volume: 78, Issue:12

    Topics: Animals; Animals, Outbred Strains; Anti-Anxiety Agents; Area Under Curve; Benzimidazoles; Biotransformation; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2C9 Inducers; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Imidazoles; Losartan; Male; Morpholines; Rats; Tetrazoles

2015
Mechanical activation of angiotensin II type 1 receptors causes actin remodelling and myogenic responsiveness in skeletal muscle arterioles.
    The Journal of physiology, 2016, 12-01, Volume: 594, Issue:23

    Topics: Abdominal Muscles; Actins; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Arterioles; Benzimidazoles; Biphenyl Compounds; Captopril; Cells, Cultured; Diglycerides; Imidazoles; Indoles; Losartan; Male; Maleimides; Muscle Development; Muscle Fibers, Skeletal; Pressure; Protein Kinase C; Pyridines; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Tetrazoles; Vasoconstriction; Vasoconstrictor Agents

2016
Mechanisms underlying the cardiac antifibrotic effects of losartan metabolites.
    Scientific reports, 2017, 02-03, Volume: 7

    Topics: Animals; Antihypertensive Agents; Blood Pressure; Cell Line; Connective Tissue Growth Factor; Fibrosis; Humans; Losartan; Male; Myocardium; Myofibroblasts; Protein-Lysine 6-Oxidase; Rats; Rats, Wistar; Transforming Growth Factor beta; Ventricular Dysfunction, Left

2017
The effect of tripterygium glucoside tablet on pharmacokinetics of losartan and its metabolite EXP3174 in rats.
    Biomedical chromatography : BMC, 2017, Volume: 31, Issue:10

    Topics: Animals; Chromatography, Liquid; Glucosides; Herb-Drug Interactions; Losartan; Male; Mass Spectrometry; Microsomes, Liver; Plant Extracts; Rats; Rats, Sprague-Dawley; Tablets; Tripterygium

2017
Conjugation to Ascorbic Acid Enhances Brain Availability of Losartan Carboxylic Acid and Protects Against Parkinsonism in Rats.
    The AAPS journal, 2018, 10-22, Volume: 20, Issue:6

    Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Ascorbic Acid; Behavior, Animal; Biological Availability; Brain; Disease Models, Animal; Drug Evaluation, Preclinical; Haloperidol; Humans; Losartan; Male; Parkinsonian Disorders; Rats; Rats, Wistar; Renin-Angiotensin System

2018
Modelling gastric emptying: A pharmacokinetic model simultaneously describing distribution of losartan and its active metabolite EXP-3174.
    Basic & clinical pharmacology & toxicology, 2020, Volume: 126, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Cross-Over Studies; Female; Gastric Emptying; Humans; Losartan; Male; Models, Biological; Therapeutic Equivalency; Young Adult

2020
Losartan metabolite EXP3174 reduces the weight of formed thrombus in 2K1C hypertensive rats.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2019, Volume: 70, Issue:3

    Topics: Animals; Antihypertensive Agents; Blood Coagulation; Blood Platelets; Blood Pressure; Hemostasis; Hypertension, Renovascular; Losartan; Male; Platelet Aggregation; Rats; Rats, Wistar; Thrombosis; Venous Thrombosis

2019
Losartan metabolite EXP3179 is a unique blood pressure-lowering AT1R antagonist with direct, rapid endothelium-dependent vasoactive properties.
    Vascular pharmacology, 2022, Volume: 147

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Endothelium; Imidazoles; Losartan; Mice; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1

2022
Sartan blood pressure regulators in classical and biofilm wastewater treatment - Concentrations and metabolism.
    Water research, 2023, Feb-01, Volume: 229

    Topics: Angiotensin II Type 1 Receptor Blockers; Biofilms; Blood Pressure; Humans; Irbesartan; Losartan; Sewage; Valsartan; Wastewater; Water Pollutants, Chemical; Water Purification

2023
    Drug metabolism and personalized therapy, 2023, 06-01, Volume: 38, Issue:2

    Topics: Antihypertensive Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C9; Humans; Hypertension; Losartan; Polymorphism, Genetic; Uric Acid

2023
Simultaneous quantification of losartan potassium and its active metabolite, EXP3174, in rabbit plasma by validated HPLC-PDA.
    Biomedical chromatography : BMC, 2023, Volume: 37, Issue:8

    Topics: Animals; Chromatography, High Pressure Liquid; Losartan; Quality Control; Rabbits; Reproducibility of Results; Valsartan

2023
Metabolomic Profile and Its Correlation with the Plasmatic Levels of Losartan, EXP3174 and Blood Pressure Control in Hypertensive and Chronic Kidney Disease Patients.
    International journal of molecular sciences, 2023, Jun-07, Volume: 24, Issue:12

    Topics: Antihypertensive Agents; Blood Pressure; Humans; Hypertension; Losartan; Renal Insufficiency, Chronic; Urea

2023
Allisartan Isoproxil Promotes Uric Acid Excretion by Interacting with Intestinal Urate Transporters in Hyperuricemic Zebrafish (Danio rerio).
    Bulletin of experimental biology and medicine, 2023, Volume: 175, Issue:5

    Topics: Animals; Hyperuricemia; Kidney; Losartan; Uric Acid; Zebrafish

2023